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ABSTRACT 
QIAN DAI: The Cochaperone and Ubiquitin ligase CHIP in Protein Quality Control 
 (Under the direction of Cam Patterson) 
Protein quality control is essential for living cells to maintain homeostasis during 
normal growth conditions as well as upon stress challenges. Molecular chaperones and 
the ubiquitin-proteasome system are the two arms of the cellular protein quality control 
system. CHIP is an Hsp70/Hsp90 cochaperone that inhibits ATPase activity of 
chaperones and enhances protein folding in vivo. CHIP is also a chaperone-dependent E3 
ubiquitin ligase that diverts chaperone substrates to the proteasome. Therefore, CHIP 
regulates both arms of the protein quality control system.  
My studies have established that CHIP regulates the stress-chaperone response 
through induced trimerization and transcriptional activation of HSF1, which leads to 
transcriptional upregulation of heat shock proteins. This upregulation is required for cells 
to cope with stress as CHIP (–/–) murine fibroblasts have decreased viability and 
increased apoptosis after heat shock or protein damaging agent treatment. Activation of 
HSF1 by CHIP is essential for the cells to cope with stress challenges. 
E3 ubiquitin ligase activity of CHIP has been implicated in the degradation of a 
variety of chaperone-bound cytoplasmic proteins. Using a proteomics approach, we have 
identified BAG2 as a common component of CHIP holocomplexes in vivo. Binding 
assays indicate that BAG2 associates with CHIP as part of a ternary complex with Hsc70.
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BAG2 is an efficient and specific inhibitor of CHIP-dependent ubiquitin ligase activity. 
This activity is due, in part, to inhibition of interactions between CHIP and its cognate 
ubiquitin-conjugating enzyme, UbcH5a. The association of BAG2 with CHIP provides a 
cochaperone-dependent regulatory mechanism for preventing unregulated ubiquitylation 
of misfolded proteins by CHIP. 
Taken together, my work has established the mechanism of CHIP to regulate the 
stress response and identified a regulatory factor for its E3 ubiquitin ligase activity. 
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In memory of my mother, Qingzhu Chen 
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General Introduction
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1.1 Molecular chaperones and protein quality control  
Molecular chaperones are a family of intracellular proteins that are responsible for 
folding newly synthesized proteins into proper structure and sending damaged proteins for 
degradation. In 1973 Anfinsen demonstrated the correct (re)folding of RNase upon removal 
of denaturant, suggesting that all the information needed for proper (re)folding was contained 
in the primary sequence of the protein(Anfinsen, 1973). However, this conclusion cannot be 
extrapolated to living cells. The major difference between the in vitro and in vivo system is 
the highly crowded environment inside the cells due to soluble and insoluble 
macromolecules, which makes spontaneous folding of proteins inside the cells unfavorable. 
Molecular chaperones have evolved to bind exposed hydrophobic patches on proteins, 
prevent them from aggregating into insoluble, nonfunctional inclusions and help them reach 
their stable native state. Molecular chaperones comprise several families of heat shock 
proteins, including the Hsp100, Hsp90, Hsp70, Hsp40, chaperonins, and small Hsps family 
proteins. Members of the Hsp100 family include the bacterial Clp proteins, the plant Hsp101 
and yeast Hsp104. They have been implicated in protein unfolding/disaggregation as well as 
direct degradation of their substrates by association with proteases (Horwich et al., 1999; 
Wickner et al., 1999). The chaperonins are a conserved class of large double-ring complexes 
of ~800 kDa enclosing a central cavity. It contains two groups. Group I chaperonins, also 
known as GroEL in bacteria or Hsp60 in eukaryotes, are generally found only in eubacteria 
and in organelles of endosymbiotic origin–mitochondria and chloroplasts. Group II 
chaperonins exist in the archaeal and the eukaryotic cytosol. The two groups are distinct in 
primary sequences but are similar in their architecture and function. They capture nonnative 
proteins through hydrophobic contacts with multiple chaperonin subunits and translocate 
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them into their central ring cavity where they fold them and protect them from aggregation 
with other nonnative proteins (Hartl and Hayer-Hartl, 2002). The small Hsp family is also 
called the HspB family, which contains 10 members from HspB1 to HspB10. This family of 
Hsps is not associated with ATP and has no protein folding activity. A representative of this 
family is HspB1/Hsp27. Although it cannot fold denatured proteins, it can adsorb heat-
denatured proteins, keep them in a folding-competent state and prevent them from 
aggregation (Ehrnsperger et al., 1997). 
In this introduction, I will focus on Hsp70 and Hsp90 family proteins because of their 
importance in eukaryotic protein quality control and their physical and functional association 
with CHIP (Carboxyl terminus of Hsc70 Interaction Protein), the protein our lab has been 
interested in and has worked on for years. 
1.1.1 The Hsp70 family proteins and their cochaperones  
 The Hsp70 family of chaperones is comprised of bacterial DnaK, yeast Ssa, Ssb, Ssc, 
mammalian stress-inducible Hsp70 and the constitutive cognate protein Hsc70, 
mitochondrial mtHsp70/Grp74 and ER Bip/Grp78. This family of proteins functions by 
binding and release of the extended nonnative polypeptide in an ATP dependent manner, 
therefore preventing nonnative protein aggregation and promoting their (re)folding. Hsp70 
contains a 45 kDa N-terminal ATPase domain, an 18 kDa central substrate binding domain, 
and a 10 kDa C-terminal domain. The structure and function of the Hsp70 family proteins 
was first demonstrated in the bacterial DnaK (Hsp70 homolog) and its cochaperone DnaJ 
(Hsp40 homolog) and GrpE (functional homolog of Hsp40). The ATPase domain of DnaK 
contains two lobes separated by a cleft where ATP is bound. The substrate binding domain of 
DnaK is divided into a β-sandwich subdomain with a peptide-binding cleft and an α-helical 
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latchlike segment (Zhu et al., 1996). DnaK binds to its substrates which have extended 
polypeptide chains, and forms hydrophobic interactions and hydrogen bonds with the side 
chain and backbone of its substrates, respectively (Zhu et al., 1996). The affinity of the DnaK 
substrate binding domain with its substrates is dependent on the ATP/ADP state of its 
nucleotide binding domain. In the ATP bound state, the α-helical latch is in an open position, 
allowing substrates to bind to the peptide binding domain. However, in this state, the 
substrate can also easily dissociate with the substrate binding domain. Therefore, the overall 
affinity of DnaK with its substrates is low in the ATP binding state. Tight binding of the 
substrates is triggered by the hydrolysis of ATP into ADP and closure of the α-helical latch, 
which results in the high-affinity substrate binding state (Bukau and Horwich, 1998; Young 
et al., 2004). The intrinsic ATPase activity of DnaK is low, and the ATP-ADP cycle is 
regulated by a group of Hsp70 interacting proteins called Hsp70 cochaperones.  
1.1.1a The Hsp40 family cochaperones 
The mammalian Hsp40 family proteins include Hdj-1 and Hdj-2, whose progenitor is E 
coli DnaJ. Both Hdj-1 and Hdj-2 contain the amino terminal signature J-domain (J-domain 
are composed of approximately 70 amino acids, including an HPD sequence), which plays an 
important role in Hsp40-Hsp70 interaction (Kelley, 1998) and an adjacent G/F-rich region; 
however, only Hdj-2 has a cysteine-rich domain. The N-terminal J domains of Hdj-1 and 
Hdj-2 bind to the carboxyl terminus of Hsp70 and stimulate the ATPase activity of Hsp70 
and thus promote the conversion of ATP-bound, low-substrate-affinity Hsp70 to ADP-bound, 
high-substrate-affinity Hsp70 (Mayer et al., 2000; Pellecchia et al., 2000). The C-terminal 
domains of Hdj-1 and Hdj-2 function as a chaperone in recognizing hydrophobic peptides 
and thus recruit Hsp70 to nascent chains (Sha et al., 2000; Rudiger et al., 2001).  
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Hdj-1 interacts with Hsp70 to fold nascent polypeptides as they emerge from cytosolic 
ribosomes and helps protect cells from thermal stress. Hdj-2, which possesses an additional 
CaaX box, a site for prenylation, has been localized to the cytosolic side of the ER membrane 
(Meacham et al., 1999). Hdj-2 has been implicated in the folding of newly synthesized cystic 
fibrosis transmembrane conductance regulator (CFTR). Hdj-2 and Hsc70 interacts with early 
folding intermediates of CFTR on the cytosolic side of the ER membrane. Hdj-2 and Hsc70 
function to prevent misfolding or aggregation of a cytosolic domain of CFTR until the 
protein is further synthesized and can undergo proper intramolecular interactions necessary 
for its proper folding (Meacham et al., 1999).  
1.1.1b The BAG family cochaperones 
The genes for BAG (Bcl2-associated athanogene) family proteins are conserved 
throughout evolution from yeast to mammals (Takayama et al., 1999). Six members of BAG 
family proteins, from BAG1 to BAG6, have been identified, with BAG1 as the founding 
member of the family(Takayama and Reed, 2001). All of the BAG family members contain a 
BAG domain near their carboxyl terminus, except BAG5, which has four putative BAG 
domains. The BAG domain is a an evolutionarily-conserved domain containing about 50 
amino acids, which allows them to interact with the ATPase domain of Hsp70 and regulates 
their function (Takayama and Reed, 2001).  
Recently the structure of the BAG domain-Hsp70 ATPase complex was resolved, 
which helps us to better understand the regulation of the BAG domain to the ATPase domain 
of Hsp70. The BAG domain opens the nucleotide-binding cleft upon binding to the ADP-
bound state of Hsp70, therefore promoting nucleotide release from Hsp70 (Briknarova et al., 
2001; Sondermann et al., 2001). Because of the excess of ATP over ADP and BAG proteins 
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in the eukaryotic cytosol, ATP will enter the nucleotide-binding pocket and displace bound 
BAG proteins, resulting in an acceleration of nucleotide exchange. Therefore, the synergistic 
action of Hsp40 and BAG protein, which stimulates ATPase activity of Hsp70 and releases 
ADP from Hsp70 respectively, results in the acceleration of the ATPase cycle of Hsp70 and 
increased substrate binding and refolding activity of Hsp70. E. coli GrpE, although 
structurally different from BAG domain, stabilizes opening of the nucleotide-binding cleft of 
the ATPase domain of DnaK similar to the binding of BAG domain to Hsp70 ATPase 
domain, and thus releases nucleotide and acts as a nucleotide exchange factor. (Brehmer et 
al., 2001)  
In addition to the conserved BAG domain, BAG family proteins also contain a 
diversity of additional domains, which allows them to interact with specific target proteins or 
which targets them to specific locations within cells, and perform functions besides 
nucleotide exchange. These functions include the regulation of signal transducing proteins 
and transcription factors important for cell stress responses, apoptosis, proliferation, cell 
migration and hormone action (Takayama and Reed, 2001) 
1.1.1c. CHIP 
CHIP (carboxyl terminus of Hsc70-interacting protein) was identified during the 
screening of the TPR (tetratricopeptide repeat)-containing proteins in the human heart cDNA 
library by the Patterson lab in 1999 (Ballinger et al., 1999). The TPR domain is a protein-
protein interaction motif. It consists of 34 amino acid residues with a loose consensus and is 
present in multiple tandem repeats (Das et al., 1998). Structural analysis of the TPR domain 
of Hop bound to the carboxyl terminus of Hsp70 or Hsp90 suggests that TPR domain has a 
helix-turn-helix conformation, which forms a “two-carboxylate-clmap” to hold the side chain 
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and carboxyl group of the terminal asparatate residue of the EEVD sequence of the carboxyl 
terminus of Hsp70 and Hsp90. Hydrophobic interactions with the divergent sequences amino 
terminal to the EEVD motif of Hsp70 or Hsp90 with the TPR domain accounts for the 
specificity of binding (Scheufler C, 2000). Since CHIP has three TPR repeats, the Patterson 
lab set out to study interactions between CHIP and Hsp70 or Hsp90 and the physiological 
consequences of these interactions.  
CHIP contains three amino-terminal TPR repeats, a central charged domain, and a 
carboxyl-terminal U-box. The interaction between CHIP and Hsc70 is mediated by the 
amino-terminal TPR domains plus the charged domain of CHIP with the carboxyl-terminus 
of Hsc70, similar to the interaction between HOP and Hsp70 or Hsp90. CHIP inhibits Hsp40-
stimulated ATPase activity of Hsp/Hsc70, and therefore inhibits both substrate binding and 
refolding activity of Hsp/Hsc70 in vitro. Thus, CHIP was implicated as a negative regulator 
of the Hsp/Hsc70 substrate-binding cycle (Ballinger et al., 1999).  
However, overexpression of CHIP in mammalian cells in vivo increases the refolding 
of proteins after thermal denaturation, which is dependent on the interaction of TPR domains 
of CHIP with Hsp70. Hsp40 competitively inhibited the CHIP-dependent refolding, which is 
consistent with in vitro data indicating that these cofactors act on Hsp70 in the ATP-bound 
state and have opposing effects on Hsp70 ATPase activity (Kampinga et al., 2003).  
To reconcile the different findings on Hsp70 refolding activity regulated by CHIP and 
Hsp40, we have to reconsider the model of Hsp70 nucleotide binding states and the coupled 
substrate binding affinity. It has been postulated that the ATP-binding state of Hsp70 has low 
substrate affinity which is unfavorable to folding, while the ADP-binding state of Hsp70 has 
high substrate affinity which favors folding. However, in the ATP-binding state, Hsp70 
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substrate binding domain is open, which allows Hsp70 to bind a variety of substrates. In the 
complicated in vivo states, a variety of cochaperones exist within cells, the relative 
abundance of each cochaperone and sum of their actions determines the overall refolding 
activity of Hsp70. Overexpressing CHIP slows down the ATPase activity of Hsp70 and 
allows a better loading of substrates onto Hsp70, which might be the rate-limiting step within 
certain cells (Kampinga et al., 2003). Therefore, it is difficult to define the endogenous role 
of a cochaperone in regulating Hsp70 refolding function based on in vitro data, given the 
complexity of the situation within the cells. 
Besides the TPR domains, CHIP has a U-box domain, which is similar to the RING-
finger domain of ubiquitin E3 ligase. Indeed, U-box domain of CHIP has ubiquitin E3 ligase 
activity, and CHIP has been suggested to be a chaperone-dependent E3 ubiquitin ligase that 
links the chaperone to the ubiquitin-proteasome system during protein quality control (Cyr et 
al., 2002; McDonough and Patterson, 2003). This function and the interaction of CHIP with 
Hsp90 will be discussed in the following parts of this dissertation. 
1.1.1d Hip and HspBP1 
Hip (Hsc70 interacting protein) was first noted as a transient component during the 
cell-free assembly of progesterone receptor complex (Smith et al., 1995) and was 
subsequently found to be associated with Hsp70 and Hsc70 (Prapapanich et al., 1996; Irmer 
and Hohfeld, 1997). Hip has an N-terminal homo-oligomerization domain and a central TPR 
repeat flanked by an acidic α-helical segment and a basic α-helix. The TPR repeats and the 
following α-helix mediate the binding of Hip with the ATPase domain of Hsc/Hsp70 
(Hohfeld et al., 1995; Prapapanich et al., 1996; Irmer and Hohfeld, 1997; Demand et al., 
1998). Hip stabilizes the ADP state of Hsc70 that has a high affinity for substrate protein 
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(Hohfeld et al., 1995; Irmer and Hohfeld, 1997). The amino-terminal homo-oligomerization 
domain does not affect the interaction between Hip and Hsp/Hsc70. It has been postulated 
that oligomerization of Hip fulfills a scaffolding function by holding multiple Hsc70 
molecules in close proximity to an unfolded polypeptide substrate (Irmer and Hohfeld, 1997). 
Besides affecting the Hsc/Hsp70 chaperone activities in vitro and in vivo (Prapapanich et al., 
1998; Nollen et al., 2001), Hip alone can also bind to unfolded proteins and prevent their 
aggregation. Yet refolding of proteins to their active state requires cooperation with other 
chaperones (Hohfeld et al., 1995; Prapapanich et al., 1996).  
HspBP1 (heat shock protein binding protein 1) was isolated from a human heart cDNA 
library using the yeast two-hybrid system (Raynes and Guerriero Jr, 1998). HspBP1 binds the 
ATPase domain of Hsp70, induces the release of either ATP or ADP from the ATPase 
domain of Hsp70, and inhibits protein refolding function of Hsp70 in vitro (Raynes and 
Guerriero Jr, 1998; Mehdi et al., 2002). Since BAG family proteins also induce the release of 
ADP from the ATPase domain of Hsp70, there is functional similarity between these two 
proteins. However, the crystal structure of HspBP1, alone and complexed with part of the 
Hsp70 ATPase domain, reveals a mechanism for its function distinct from that of BAG1 or 
GrpE. HspBP1 has a curved, all alpha-helical fold containing four armadillo-like repeats 
unlike the other nucleotide exchange factors. The concave face of HspBP1 embraces lobe II 
of the ATPase domain of Hsp70, and a steric conflict displaces lobe I, reducing the affinity 
for nucleotide. In contrast, BAG-1 and GrpE trigger a conserved conformational change in 
lobe II of the ATPase domain. Thus, two distinct mechanisms account for nucleotide 
exchange on eukaryotic Hsp70 (Yasuhito et al., 2005). 
1.1.2 The Hsp90 family proteins and their cochaperones 
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The Hsp90 chaperone family is highly conserved throughout evolution. It includes the 
eponymous Hsp90 (90 kD heat shock protein) of the eukaryotic cytosol, termed variously 
Hsp90α and β in humans (corresponding to a major and minor isoform), Hsp86 and Hsp84 in 
mice, Hsp83 in Drosophila, and Hsc82 and Hsp82 in yeast. Other family members are HtpG 
in the bacterial cytosol, Grp94/gp96 in the endoplasmic reticulum of eukaryotes, and the 
Hsp75/TRAP1 in the mitochondrial matrix (Argon and Simen, 1999; Felts et al., 2000; 
Thomas and Baneyx, 2000). These proteins have a common structural composition and are 
thus expected to have a similar mechanism of action. Hsp90 has a COOH-terminal 190-
residue  dimerization domain that forms constitutive Hsp90 homodimer (Nemoto et al., 
1995), and a highly conserved 25 kDa NH2-terminal domain that is the binding site for ATP 
and for geldanamycin (GA) (Prodromou et al., 1997; Stebbins et al., 1997). GA is a 
representative of the ansamycin drugs that are specific inhibitors of Hsp90 (Whitesell et al., 
1994). Both the NH2- and COOH-terminal domains of Hsp90 are able to bind to substrate 
polypeptides, and substrate binding at the NH2-terminal site is affected by nucleotides, GA, 
and the adjacent charged sequence of Hsp90 (Young et al., 1997; Scheibel et al., 1998; 
Scheibel et al., 1999). Similar to the other ATP-dependent chaperones, the interaction of 
Hsp90 with substrate polypeptides is regulated by the ATPase cycle (Prodromou et al., 1997; 
Obermann et al., 1998; Panaretou et al., 1998). 
Unlike Hsp70, eukaryotic cytosolic Hsp90 does not act generally in nascent protein 
folding (Nathan et al., 1997). Hsp90 is distinguished from other chaperones in that most of its 
known substrates are signal transduction proteins, the classical examples being steroid 
hormone receptors and signaling kinases (Picard et al., 1990; Xu and Lindquist, 1993). 
Because Hsp90 is essential for maintaining the activity of numerous signaling proteins, it 
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plays a key role in cellular signal transduction networks. A common feature of many Hsp90 
clients, including steroid hormone receptors and signaling kinases, is a tendency to dwell in 
incompletely folded or aggregation-prone states. These proteins dynamically cycle through 
complexes with Hsp90 and other cofactors until their activation is engendered by the proper 
signal. (Jakob et al., 1995) In fulfilling its role, Hsp90 operates as part of a multichaperone 
machinery in the cytosol, which includes Hsp70 and other cochaperones (Bose et al., 1996; 
Freeman et al., 1996). 
The largest class of cochaperones binds to Hsp90 via a modular domain containing 
typically three TPR repeats. These TPR domains are fused to a series of different functional 
domains, for example peptidyl-prolyl isomerase domains (the cyclophilin Cyp40 and the 
immunophilins FKBP52 and FKBP51) (Johnson and Toft, 1994) or a protein phosphatase 
(PP5) (Chen et al., 1996a), or other TPR domains that brings Hsp70 and Hsp90 into a 
multichaperone complex (Hop) (Chen and Smith, 1998; Johnson et al., 1998), or a U-box that 
diverts Hsp90 bound glucocorticoid receptor for proteasomal degradation (CHIP)  The TPR 
containing cochaperone CHIP associates with Hsp90 containing glucocorticoid receptor-
chaperone heterocomplexes and diverts chaperone substrate for proteasomal degradation 
(Connell et al., 2001).  
In the following paragraphs I will briefly introduce Hsp90 cochaperones Hop and p23 
as examples of cochaperone regulation of Hsp90 functions. 
1.1.2a. Hop containing chaperone complexes 
Hop (Hsp organizer protein) is composed almost exclusively of TPR domains and does 
not function as a chaperone on its own (Honore et al., 1992; Smith et al., 1993). Hop has nine 
TPR motifs that form two TPR domains. The amino-terminal TPR1 domain that contains 
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three TPR motifs is responsible for the interaction with the carboxyl-terminus of Hsp70, and 
the carboxyl-terminal TPR2 domain that contains six TPR motifs mediates the interaction of 
Hop with Hsp90 (Chen et al., 1996b; Lassle et al., 1997; Demand et al., 1998). Therefore 
Hop links the Hsp70 with the Hsp90 chaperone system. As with Hsp70, the binding site for 
Hop on Hsp90 is the carboxyl-terminal EEVD motif of Hsp90 (Scheufler C, 2000). 
Hop inhibits the Hsp90 ATPase (Prodromou et al., 1999) and blocks access of ATP or 
the inhibitor geldanamycin to its binding pocket in the NH2-terminal domain of Hsp90 
(Prodromou et al., 1997; Stebbins et al., 1997; Prodromou et al., 1999). This inhibitory 
activity of Hop has been proposed to be part of a substrate-loading mechanism for Hsp90, 
where an Hsp90-Hop-Hsp70 complex permits transfer of substrate polypeptide from Hsc70 
to the nucleotide-free state of Hsp90 (Prodromou et al., 1999). Binding of ATP onto Hsp90 
then displaces the Hop-Hsc70 loading system and simultaneously closes the substrate-
binding clamp of Hsp90. Although such a loading mechanism remains to be demonstrated 
directly, it is consistent with earlier time course experiments, showing that initial binding of 
Hsc70, Hop, and Hsp90 to progesterone receptor was followed by the dissociation of Hsc70 
and Hop, leading to “mature” Hsp90 complexes (Smith et al., 1993; Hutchison et al., 1994).  
1.1.2b p23 containing chaperone complexes 
p23 (Sba1 in yeast), which is unrelated to the TPR domain proteins, is a small protein 
with chaperone activity that binds unfolded polypeptides (Bose et al., 1996; Freeman et al., 
1996) and also interacts with the NH2-terminal domain of Hsp90. The active core domain of 
p23 has an immunoglobulin-like fold with several highly conserved residues exposed in one 
cluster, forming the probable contact site for Hsp90 (Weaver et al., 2000). The core domain 
of p23 is sufficient for its ATP-dependent action on Hsp90 (Young and Hartl, 2000), whereas 
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the chaperone activity of p23 resides in a separate carboxyl terminal domain (Weikl et al., 
2000).  
p23 and Sba1 recognize specifically the ATP-bound state of Hsp90(Sullivan et al., 
1997; Fang et al., 1998), which is present in the mature form of Hsp90 complexes. Although 
p23 does not affect the ATPase activity of Hsp90, it significantly stimulates the ATP 
hydrolysis-dependent dissociation of Hsp90-substrate complexes. One possible mechanism is 
that p23 more stringently couples the nucleotide state of Hsp90 with conformational changes 
throughout the dimer (Young and Hartl, 2000).  
1.2 Heat shock response and its regulation 
The heat shock response is an ordered genetic response to diverse environmental and 
physiological stressors that results in the immediate induction of genes encoding molecular 
chaperones, proteases, and other proteins essential for protection and recovery from cellular 
damage. The rationale behind this phenomenon is that after stress there is increased need for 
the chaperone function of heat shock proteins, which triggers their induction. This need is 
caused by the increased amount of damaged proteins, by the inhibition of their elimination 
via the proteasome as well as by the damage of the chaperones themselves. The induction of 
heat shock proteins therefore helps to bind unfolded proteins and hold them in folding-
competent states for further refolding and prevent them from aggregation.  
The heat shock response is regulated at the transcriptional level by the activation of a 
family of heat shock transcription factors (HSF) (Pirkkala et al., 2001). HSF1-4 have been 
identified in vertebrates and plants . Among them, HSF1 is the best characterized and 
essential for the heat shock response. HSF2 is important in developmentally related 
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conditions. HSF3 exists only in avian species. Less function has been assigned to HSF4. 
(Pirkkala et al., 2001; Voellmy, 2004)  
1.2.1 HSF1 as the major transcription factor responsible for stress response 
The DNA binding and transcriptional activities of HSF1 are stress-inducibly regulated 
by a multistep activation pathway. HSF exists normally in a repressed state as an inert 
monomer in either the cytoplasmic or nuclear compartments. Upon exposure to a variety of 
stresses, HSF1 is derepressed, trimerizes, and accumulates in the nucleus. HSF1 trimers bind 
with high affinity to the heat shock elements (HSEs) consisting of multiple contiguous 
inverted repeats of the pentamer sequence nGGAn located in the promoter regions of target 
genes (Wu, 1995). The HSF1 regulated genes encoding Hsp70, Hsp90, and small Hsps are 
also transcribed constitutively due to multiple basal factors or binding of low levels of HSF1.  
1.2.2 Regulation of HSF1 activity 
Several mechanisms have been suggested to regulate HSF1 activity, which includes the 
regulation by molecular chaperones Hsp70, Hsp90 and cochaperone Hsp40, posttranslational 
modification by phosphorylation and sumoylation, and the regulation by redox status (Zhong 
et al., 1998; Ahn and Thiele, 2003; Voellmy, 2004; Westerheide and Morimoto, 2005). This 
complicated system of the regulation of HSF1 may reflect the necessity to tightly control the 
expression of molecular chaperones. 
1.2.2a Regulation by molecular chaperones 
Both Hsp70 and Hsp90 have been implicated in the regulation of HSF1 (Morimoto, 
1998). The substrate binding domain of Hsp70 interacts with the activation domain of HSF1 
that features chaperone-substrate binding. This interaction has been suggested to be 
responsible to repress HSF1 during the attenuation phase of heat shock response. Therefore, 
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the induced Hsp70 exerts a feed-back control to limit the extent of heat shock response.  
(Abravaya et al., 1992; Shi et al., 1998) 
Hsp90 has also been suggested to suppress HSF1. Hsp90-immunophilin-p23 complex 
interacts with the regulatory domain of HSF1 and suppresses the transcriptional activity of 
trimeric HSF1. During stress response when there is increased amount of denatured proteins, 
Hsp90-immunophilin-p23 complexes are diverted to bind to denatured proteins, or when 
Hsp90 or p23 are depleted by antibody in experimental conditions, HSF1 is released from the 
chaperone complexes, becomes trimerized and activated spontaneously (Zou et al., 1998; 
Guo et al., 2001). Formation of the heterocomplex may also represent the first step toward 
returning the HSF1 to its unactivated form. 
1.2.2b Modification by phosphorylation and sumoylation 
HSF1 is constitutively phosphorylated and becomes hyperphosphorylated upon stress 
stimuli (Cotto et al., 1996; Knauf et al., 1996; Xia and Voellmy, 1997; Chu et al., 1998). 
Sites of HSF1 constitutive phosphorylation, including serines 303, 307 and 308, appear to be 
important for the negative regulation of HSF1, whereas sites of inducible phosphorylation, 
including serines 230, 326 and 419, promote HSF1 activity (Holmberg et al., 2001; 
Guettouche et al., 2005; Kim et al., 2005). The balance of kinase and phosphatase activities 
acting on HSF1 is of fundamental importance to regulation of the heat shock response, as 
suggested by mathematical modeling (Rieger et al., 2005).  
SUMO (Small ubiquitin-like modifier) is a protein of 97 amino acids that is structurally 
similar to ubiquitin (Melchior, 2000). Like ubiquitin, SUMO has been found to be covalently 
attached to certain lysine residues of specific target proteins (Melchior, 2000). In contrast to 
ubiquitylation, however, sumoylation does not promote the degradation of proteins but 
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instead alters a number of different functional parameters of proteins, such as subcellular 
localization, protein partnering, and DNA-binding and/or transactivation functions of 
transcription factors (Hay, 2005). While HSF1 is sumoylated on lysine 298 in a manner that 
requires phosphorylation on serines 303 and 307 (Hong et al., 2001; Hietakangas et al., 
2003), the role of this modification on HSF1 activity is still unclear.  
1.2.2c Redox regulation of HSF1 
Both heat and hydrogen peroxide can induce trimerization and DNA binding of 
recombinant Drosophila or mammalian HSF1 directly and reversibly in vitro (Zhong et al., 
1998; Ahn and Thiele, 2003). Further examination of the mammalian HSF1 elucidated that 
two cysteine residues within the HSF1 DNA-binding domain are required to sense both 
stresses and are engaged in redox-sensitive disulfide bonds. Mutations in either or both of the 
cysteine residues lead to defects in stress-inducible trimerization and DNA binding, stress-
inducible nuclear translocation and Hsp gene transactivation, and in the protection of mouse 
cells from stress-induced apoptosis (Ahn and Thiele, 2003). Thus, the redox-dependent 
activation of HSF1 by heat and hydrogen peroxide establishes a common mechanism in the 
stress activation of Hsp gene expression by HSF1. 
1.3 The ubiquitin-proteasome system 
1.3.1 Discovery of the protein degradation system 
Tight control of protein synthesis, activity and removal from the cellular repertory is 
important to maintain homeostasis. When cellular proteins are damaged or unnecessary, they 
need to be removed. Timing and fine control of protein degradation is equally as important as 
the control of gene expression. Originally thought to be carried out by cellular proteases by 
simple chemical catalysis, now it is well-established that protein degradation requires the 
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complicated ubiquitin-proteasome system (Glickman and Ciechanover, 2002). In 1984, 
Ciechanover and Finley (Ciechanover et al., 1984; Finley et al., 1984) discovered that in the 
temperature sensitive ts85 cells, a mutation of the ubiquitin activating enzyme E1 caused a 
marked defect of ubiquitin conjugation in cells grown in non-permissive temperature 
compared with cells grown in permissive temperature. Importantly, turnover of abnormal or 
truncated polypeptides was inhibited by more than 80%, and turnover of short-lived protein 
was inhibited by more than 90% when cells were grown in non-permissive temperature. This 
discovery provided a cause and effect relationship between protein ubiquitylation and 
degradation for the first time. After exploration of this system for two decades, we now know 
more details about this system. 
1.3.2 Players of the system 
1.3.2a Ubiquitin 
Ubiquitin is a highly conserved 76 amino acid polypeptide that can be joined to a 
substrate via an isopeptide bond of the carboxyl terminal glycine of ubiquitin with the lysine 
of its substrate in the presence of ATP. Once an ubiquitin molecule is added onto a substrate, 
a subsequent polyubiquitin chain is formed by isopeptide bond between carboxyl terminus of 
one ubiquitin and lysine residue of the previously conjugated ubiquitin. Most polyubiquitin 
chains form via a lysine (K) 48 link, which usually leads to substrate degradation. Other 
links, including K11, K29 and K63 are also present in vivo. K63-linked chains are believed 
to act as signaling molecules in diverse cellular pathways including endocytosis, stress 
response, and DNA repair (Spence et al., 1995; Soetens et al., 2001; Wang et al., 2001). Less 
is known about the K11 or K29 link.  
1.3.2b E1, E2, E3 
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Protein ubiquitylation is a sequential enzymatic reaction requiring the E1 ubiquitin 
activating enzyme, the E2 ubiquitin conjugating enzyme, and the E3 ubiquitin ligase (Pickart, 
2001; Glickman and Ciechanover, 2002). E1 catalyzes the activation of ubiquitin by forming 
a thioester bond between its cysteine residue and the carboxyl terminal glycine of ubiquitin at 
the expense of ATP. The activated ubiquitin is then transferred to a cysteine residue of an E2 
ubiquitin conjugation enzyme, and further to the substrate in an E3 ubiquitin ligase 
dependent manner (Hershko et al., 1983). To date one E1, dozens of E2s and hundreds of E3s 
have been identified in mammalian cells, which is consistent with substrate specificity 
conferred by E3. There are two canonical types of E3 enzymes, i.e., the HECT (Homologous 
to E6-AP Carboxyl Terminus) domain E3s (Huibregtse et al., 1993; Huibregtse et al., 1995) 
and the RING (Really Interesting New Gene) finger domain E3s (Tyers and Willems, 1999; 
Joazeiro and Weissman, 2000). Recently the U-box proteins joined the E3 family (Murata et 
al., 2001; Cyr et al., 2002; Patterson, 2002). 
 All E3 enzymes possess two features: interaction with specific E2 and recognition of 
their cognate substrates. The HECT domain E3s are “true” E3 ligases because they pass 
ubiquitin from E2s to their cysteine residues and then on to their substrates (Scheffner et al., 
1995). The structure of HECT domain E3s, which is highly conserved, is modular: The 
unique NH2-terminus of each family interacts with specific substrates, and the COOH-
terminal HECT domain mediates E2 binding and catalysis of ubiquitin chain formation 
(Huang et al., 1999). A representative of this family E3s is E6-AP (E6-associated protein). 
E6-AP forms complex with HPV viral protein E6 to ubiquitylate p53 (Scheffner et al., 1993). 
Several other members of this family, including Smurf1, Itch, and hrFP1/Nedd4 have been 
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identified which catalyze polyubiquitin chain formation in similar mechanism (Pickart, 
2001). 
The RING finger family E3s is characterized by harboring a series of histidine and 
cysteine residues with characteristic spacing that allows for the coordination of two zinc ions 
in a cross-brace structure called a RING finger (Saurin et al., 1996; Borden, 2000). The zinc 
bound residues are catalytic inert, and it is the spacing of the zinc ligand, rather than the 
sequence in between these ligand residues, that is conserved in the U-box family (Aravind 
and Koonin, 2000). These features suggest that the RING finger is a scaffold motif rather 
than a substrate recognition domain or an E3 ligase per se (Borden, 2000). The RING finger 
domain interacts with E2 and other domains of the RING finger protein or proteins 
complexed with it in order to recognize the substrate. RING finger domain E3s do not have 
active cysteine residues to form E3-ubiquitin intermediate as the HECT domain E3s do, 
rather they facilitate the transfer of ubiquitin from E2s to their substrates (Freemont, 2000). 
However, the precise mechanism of the catalysis is not clear. The RING finger domain-
containing E3 family is composed of two distinct groups, single subunit and multisubunit 
proteins. Single subunit proteins are monomers or homodimers and contain both the RING 
finger domain and the substrate-binding/recognition site in the same molecule. Examples of 
single subunit E3s are c-Cbl, Mdm2, and Parkin with their substrates of EGF and PDGF 
receptor, p53, and Pael receptor respectively (Joazeiro et al., 1999; Boyd et al., 2000; Geyer 
et al., 2000; Shimura et al., 2000). Multisubunit RING E3s are classified into three 
subfamilies: SCF (Skp1-Cullin-F-box protein) complexes, the APC (Anaphase Promoting 
Complex) E3s, and the VCB (von-Hippel-Lindau-Elongins B and C) E3s. These complexes 
have been reviewed extensively (Pickart, 2001; Jackson and Eldridge, 2002; Peters, 2003); 
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here I will briefly introduce the SCF complex as an example. In this complex, the F-box 
protein recognizes the substrates, Skip and Cullin act as adaptors to bring the other 
components of the complex together. Rbx1 (Hrt1/Roc1), the RING finger domain protein, 
brings ubiquitylated E2 and acts as a scaffold protein (Kamura et al., 1999; Skowyra et al., 
1999). The SCF complexes and the APC complexes play important roles in cell cycle control 
as they degrade specific cyclins that control the activity of CDKs.  
Recently the U-box family proteins were identified as a new family of E3 ubiquitin 
ligases (Patterson, 2002; Hatakeyama and Nakayama, 2003). The U-box forms a structure 
similar to the RING finger domain. However, it does not have the conserved histidine and 
cysteine residues required to stabilize the RING finger structure. Instead the U-box structure 
is stabilized by a more decentralized set of hydrogen-bonding and ionic-bridging interactions 
than that provided by the zinc ions in the RING finger domain (Ohi et al., 2003). Given the 
structural similarity of U-box with RING finger domain, it was inferred that the U-box has 
E3 ligase activity. Yeast Ufd2, the first member of this family of proteins identified, was 
defined as an E4 polyubiquitin chain assembly factor. Ufd2 can not catalyze polyubiquitin 
chain formation on its substrate de novo. However, it is required for efficient polyubiquitin 
chain formation with Ufd4 (a yeast HECT domain E3) and to trigger proteasomal 
degradation of artificial substrates (Koegl et al., 1999). CHIP, which was originally identified 
as a negative regulator of Hsc/HSP70 molecular chaperones via the interaction of the TPR 
domain of CHIP to the carboxyl terminal EEVD motif of chaperone (Ballinger et al., 1999), 
has been identified as a U-box dependent E3 ubiquitin ligase (Connell et al., 2001; Jiang et 
al., 2001; Meacham et al., 2001). In addition to CHIP, several other U-box proteins, i.e., 
UIP5, CYC4, and PRP19, have also been shown to possess E3 ligase activity in the absence 
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of other E3 components, proving that U-box proteins are a new family of E3 ubiquitin ligase 
(Hatakeyama and Nakayama, 2003).  
1.3.2c The proteasome 
Multiple substrate-linked polyubiquitin chains signal the recruitment of the 
proteasome-the 2.5 MDa degradation machinery. The proteasome is composed of the 19S 
regulatory particle and the 20S core particle. The 19S regulatory particle recognizes 
polyubiquitylated substrates (Thrower et al., 2000), removes ubiquitin chain from the 
substrates (Eytan et al., 1993; Lam et al., 1997; Holzl et al., 2000), unfolds and translocates 
the substrates to the 20S core proteasome, where the substrates are degraded into small 
peptides (Lam et al., 1997). Polyubiquitin chain removal, substrate unfolding and 
translocation must be precisely coordinated in order for successful degradation of the 
substrate, which has been reviewed previously (Pickart and Cohen, 2004). 
1.4 Functions of CHIP in protein quality control 
CHIP was originally identified as a TPR domain containing cochaperone that interacts 
with Hsp/Hsc70 and negatively regulate Hsp/Hsc70 chaperone function (Ballinger et al., 
1999). Subsequently CHIP was suggested to induce the degradation of Hsp90 client 
glucocorticoid receptor (GR) and chaperone associated, inefficiently folded forms of CFTR 
(Connell et al., 2001; Meacham et al., 2001). The direct evidence that the U-box of CHIP 
contains E3 ubiquitin ligase activity came from the in vitro reconstitution of polyubiquitin 
chain formation catalyzed by CHIP and the identification of UBC4 and UBCH5 as the E2s 
that couple with CHIP (Jiang et al., 2001; Murata et al., 2001). Although the function of 
Hsc70 ubiquitylation has unknown function (Jiang et al., 2001), the fact that CHIP 
ubiquitylates heat denatured luciferase that is captured by chaperones Hsp90 or Hsp70 and 
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Hsp40, with the previous findings that CHIP degrades GR and CFTR, suggests that CHIP is 
a quality-control E3 that selectively ubiquitylates unfolded or misfolded chaperone 
substrates, thus provides a link between the chaperone and the proteasome system. 
Global suppression of chaperone function and diversion of chaperone substrate to the 
degradation pathway by CHIP are unfavorable for the cells to survive stress challenges as 
well as to maintain function in normal growth conditions. In chapter two, we studied the 
endogenous function of CHIP during stress conditions and found that CHIP confers 
protection against apoptosis and cellular stress by activating HSF1 and increasing the 
expression of Hsp70. In Chapter three, we examined CHIP-containing complexes and found 
that BAG2, a previously uncharacterized BAG domain protein, is a major component of 
these complexes. BAG2 suppresses CHIP-dependent E3 ligase activity specifically and 
efficiently. Thus, our work provides addition information about the function and regulation 
of CHIP in protein quality control. 
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2.1 Abstract 
Induction of molecular chaperones is the characteristic protective response to 
environmental stress, and is regulated by a transcriptional program that depends on heat 
shock factor 1 (HSF1), which is normally under negative regulatory control by molecular 
chaperones Hsp70 and Hsp90. In metazoan species, the chaperone system also provides 
protection against apoptosis. We demonstrate that the dual function co-chaperone/ubiquitin 
ligase CHIP (C-terminus of Hsp70-interacting protein) regulates activation of the stress-
chaperone response through induced trimerization and transcriptional activation of HSF1, and 
is required for protection against stress-induced apoptosis in murine fibroblasts. CHIP exerts 
a central and unique role in tuning the response to stress at multiple levels by regulation of 
protein quality control and transcriptional activation of stress response signaling. 
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2.2 Introduction 
Protection from cellular stress is a fundamental function that enables all living 
organisms to counteract noxious environmental stimuli. A crucial aspect of the heat shock 
response is the rapid and massive production of distinct classes of related proteins conserved 
in evolution, including heat shock proteins 70 and 90, which can account for several percent 
of all proteins within a cell in times of stress. Although originally appreciated as a 
mechanism for protection against thermal stress, the so-called heat shock response is 
activated by a range of other stressors (including osmotic changes, ischemia and aging) all of 
which have the accumulation of misfolded proteins as a central feature. Heat shock proteins 
act as molecular chaperones that bind to misfolded proteins, prevent their aggregation and aid 
their refolding. In addition, functions distinct from their chaperone activity have emerged. 
Both Hsp70 and Hsp90 assist in the delivery of fatally damaged proteins to the ubiquitin–
proteasome protein degradation machinery and modulate the apoptotic response (Schneider et 
al., 1996; Bercovich et al., 1997; Gabai et al., 1997; Mosser et al., 1997; Beere and Green, 
2001); therefore, the overall function of heat shock proteins is to promote cellular survival by 
providing a protected environment within the cell until non-native proteins can be folded or 
cleared.  
Expression of heat shock proteins is tightly controlled at the transcriptional level 
through regulation of heat shock factor 1 (HSF1). HSF1 is repressed by Hsp90, Hsp70 and 
HDJ1 (Hsp40) during quiescent state (Shi et al., 1998; Zou et al., 1998). Upon activation, 
HSF1 becomes trimerized, acquires posttranslational modification such as phosphorylation, 
and is translocated into the nucleus, where it binds to heat shock elements (HSEs) located in 
the promoters of heat shock proteins (Morimoto, 1998). Molecular chaperones, including 
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Hsp70, Hsp90 and HDJ1 (Hsp40), also play a role in the attenuation phase of HSF1 
activation (Rabindran et al., 1994; Shi et al., 1998; Zou et al., 1998). In particular, Hsp70 
interacts with the transactivation domain of HSF1 and attenuates HSF1 activity, in part by 
preventing recruitment of the general transcriptional machinery and also by stabilizing the 
monomeric conformation (Shi et al., 1998). Repression of HSF1 activity by stress-inducible 
chaperones forms a feedback regulation of the HSF1 activation pathway, which is under tight 
control at multiple levels (Zuo et al., 1995).  
Activities of molecular chaperones of Hsp70 and Hsp90 are controlled by families of 
accessory proteins called co-chaperones [reviewed in (Luders et al., 1998)]. For Hsp70, these 
co-chaperones regulate cycles of ATP binding, hydrolysis into ADP and nucleotide exchange 
of ADP with ATP, which in turn control substrate affinity and folding activity. One such co-
chaperone, CHIP (C-terminus of Hsp70-interacting protein), interacts with Hsp70 (and also 
Hsp90) via three tandem tetratricopeptide repeat (TPR) motifs. CHIP, which is highly 
conserved in metazoan species, regulates the Hsp70 folding cycle by attenuating Hsp70 
ATPase activity and substrate affinity and therefore reducing the rate of refolding measured 
in vitro (Ballinger et al., 1999). In addition to its N-terminus TPR motifs, CHIP also contains 
a U-box at its C-terminus (Aravind and Koonin, 2001); this RING finger-like domain has 
ubiquitin ligase activity, and CHIP facilitates the ubiquitylation and subsequent proteasome-
dependent degradation of several chaperone substrates (Connell et al., 2001; Jiang et al., 
2001; Meacham et al., 2001). Thus, CHIP provides a direct link between the chaperone and 
proteasome systems, and is postulated to assist in regulating the cellular balance between 
folding and degradation (McClellan and Frydman, 2001). 
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Although we now know that CHIP is a negative regulator of Hsp70 refolding activity 
in vitro and a chaperone-dependent E3 ubiquitin ligase in vivo, the overall endogenous 
function of CHIP, especially under stress conditions, is unknown. In this study, we set out to 
examine the effect of CHIP overexpression on the chaperone system and the role of 
endogenous CHIP during stress response with cells derived from CHIP (–/–) mice. Our 
results provided a mechanism for an unexpected function of CHIP, and thus suggesting a 
pivotal role of CHIP for the fine tuning of stress response.  
2.3 Materials and methods 
Cell culture -- COS7 cells were cultured as previously described (Connell et al., 
2001). HSF1 (–/–) and HSF1 (+/+) murine embryonic fibroblasts were provided by Ivor 
Benjamin (McMillan et al., 1998; Xiao X, 1999) and CHIP (–/–) and CHIP (+/+) fibroblasts 
were cultured according to standard protocols. Recombinant adenoviruses expressing CHIP 
or control viruses were constructed with the Ad-Easy system and cultures were routinely 
infected at a multiplicity of infection of five with an infection efficiency of >98%. Western 
blotting and immunoprecipitations were performed as previously described (Connell et al., 
2001). 
Reporter gene and electrophoretic mobility gel shift assays (EMSAs) -- Hsp70 
promoter:reporter constructs were provided by David Latchman (Stephanou et al., 1999). 
Reporter constructs were co-transfected in COS7 with a ß-galactosidase reporter (to control 
for transfection efficiency), with or without plasmids expressing CHIP, CHIP mutants or 
other co-chaperones as indicated. For EMSA, a radiolabeled HSE oligonucleotide was 
incubated with nuclear extract from cells treated as indicated. The reaction mixture was 
incubated at room temperature for 20 min and fractionated on a 5% native polyacrylamide 
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gel in 0.5x TBE buffer. To determine the specificity of the DNA–protein complexes, we 
performed competition assays using 50-fold molar excess of the unlabeled double-stranded 
HSE oligonucleotide (specific inhibitor) or excess of an unrelated NFκB oligonucleotide of 
comparable length (non-specific inhibitor). To characterize specific DNA-binding proteins, 
we incubated nuclear extracts with anti-HSF1 or anti-HSF2 antibody before adding probe.  
Assays of apoptosis -- CHIP (+/+) and CHIP (–/–) fibroblasts were incubated at 37°C, 
or heated at 42°C for 30 min, followed by 6 h recovery at 37°C and heated again at 45°C for 
45 min (to stimulate maximal preconditioning), or only heated at 45°C for 45 min. Cells were 
incubated at 37°C as indicated in the figure legends before lysing. Viability was measured 
with the XTT Assay (Roche). Caspase 3 activity was measured using a fluorometric assay 
(Roche). Cleaved caspase 3, which is the activated form of the enzyme, was detected with 
cleaved caspase 3 (Asp175) antibody 9661 (Cell Signaling Technology), which detects only 
the active form of caspase 3.  
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Figure 2.1 Expression of heat shock proteins induced by CHIP overexpression. 
(A) Coomassie Blue gel of lysates from COS7 cells infected with an adenovirus 
expressing CHIP demonstrates increased expression of a 70-kDa protein compared 
with cells infected with a control adenovirus. (B) Western blot analysis indicates that 
expression of the chaperones Hsp27, Hsp90α and especially Hsp70 is increased by 
CHIP. 
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Figure 2.2 Induction of Hsp70 by CHIP is not additive to the effects of heat 
shock. (A) COS7 cells infected for 24 h with an adenovirus expressing CHIP or a 
control adenovirus were subjected to heat shock at 42°C for the indicated times. 
Hsp70 induction by CHIP was comparable to, and not additive with, that induced by 
heat shock. (B) Hsp70 promoter:reporter constructs containing (+HSE) or lacking (-
HSE) the HSF1 response element were transiently co-transfected with CHIP 
expression vectors and reporter activity was determined 48 h after transfection, with 
or without heat shock (42°C). CHIP transactivates the Hsp70 promoter in an HSE-
dependent fashion, as does heat shock. 
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2.4 Results 
CHIP increases Hsp70 expression by activation of transcription factor HSF1 -- In 
order to understand the cellular function of CHIP, we used an adenoviral approach to 
overexpress CHIP or GFP as a control in COS7 cells, which express CHIP endogenously at 
low but detectable levels. We examined the protein expression profile of cells at different 
time point after viral infection with SDS-PAGE followed by Coomassie Blue staining. We 
found that overexpression of CHIP elevated the levels of a highly inducible 70 kDa protein 
(Figure 2.1A). Based on the size and abundance of this protein, we suspected that this protein 
was the inducible form of heat shock protein 70. Western blot analysis confirmed that this 
protein is indeed Hsp70. In addition, we blotted the membrane with antibodies against 
several other chaperones, and found that protein levels of Hsp90α and Hsp27 are also 
increased in cells overexpressing CHIP (Figure 2.1B). Therefore overexpression of CHIP 
mimics heat shock stimuli in terms of heat shock proteins induction. This unique observation 
of co-chaperone-dependent Hsp70 expression led us to consider its mechanisms and 
functional consequences in more detail. 
We compared the expression of Hsp70 in cells overexpressing CHIP without heat 
shock or at different time points after heat shock. We found that induction of Hsp70 was 
comparable to and not additive with the effects of heat shock (Figure 2.2A). This result 
suggests that CHIP and heat shock activate Hsp70 through the same pathway. Expression of 
heat shock proteins by heat shock is controlled at the transcriptional level by the binding of 
heat shock factor 1 (HSF1) to the heat shock element (HSE) located in the promoters of heat 
shock proteins (Wu, 1995). We then investigated whether CHIP activated the same pathway 
as heat shock does. We used reporter gene assays to examine whether heat shock element is  
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Figure 2.3 Activation of HSF1 by CHIP is required for Hsp70 induction. (A) HSF1 DNA 
binding activity to the HSE was assessed by gel shift assay. Expression of CHIP enhances 
binding of two specific bands (SB), which are competed away by unlabeled HSE but not by 
an NF B consensus sequence. The binding activities can be supershifted (SS) with an HSF1, 
but not an HSF2, antibody. NS, nonspecific. (B) Upregulation of Hsp70 in response to CHIP 
48 h after transfection was determined in wild-type or HSF1-null murine fibroblasts by 
western blot analysis. 
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required for CHIP-dependent induction of Hsp70. CHIP expression potently activated Hsp70 
promoter activity (Figure 2.2B). The activation by CHIP was comparable to that induced by 
but again not additive with the effect of heat shock and was abolished in a promoter fragment 
that lacked the HSE, indicating that this effect is dependent on the interaction of HSE with its 
binding protein(s). We then used gel mobility shift assays to directly examine the protein(s) 
that mediated the transcriptional effects of CHIP (Figure 2.3A). Overexpressing CHIP 
enhanced a specific binding of nuclear proteins to the radiolabeled HSE. This binding could 
be competed by a molar excess of unlabeled HSE but not by a non-specific sequence NF-κB. 
When we used antibody to HSF1, but not that to HSF2, the mobility of this binding was 
retarded, proving that HSF1 was the protein that was activated by CHIP.  Finally, we 
confirmed that HSF1 was necessary for the induction of Hsp70 by CHIP in fibroblasts from 
mice deficient in HSF1 (McMillan et al., 1998; Xiao X, 1999). CHIP upregulated Hsp70 
appropriately in wild-type fibroblasts, but not in cells lacking HSF1 (Figure 2.3B). In fact, we 
observed modest downregulation of basal Hsp70 levels by CHIP in HSF1-null cells. This 
indicates that CHIP has effects on more than one signaling pathway that regulates Hsp70 
expression. HSF1-dependent regulation is clearly the dominant pathway and probably the 
only positive regulatory pathway affected by CHIP. When this effect is removed, other minor 
negative regulative pathways become dominant. This also explains the data of figure 2.2B. 
It has been well-documented that both Hsp70 and Hsp90 can repress the activation of 
HSF1 (Morimoto, 1998; Shi et al., 1998; Zou et al., 1998), as can other co-chaperones such 
as HspBP1 (Hu and Mivechi, 2003), making the activation of HSF1 by CHIP an exceptional 
observation. To test the specificity of this effect, we examined a panel of co-chaperones for 
their ability to increase Hsp70 expression and promoter activity. In comparison with other co- 
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Figure 2.4 Activation of HSF1 is specific to CHIP. (A and B) Only overexpression of 
CHIP, but not other co-chaperones [protein phosphatase 5 (PP5), FKBP59, cdc37, 
BAG-1, HDJ2 or HOP], increases Hsp70 protein expression (B) and promoter activity 
(C) after transient transfection.  
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Figure 2.5 Activation of HSF1 is dependent on chaperone interactions. (A) Western 
blot analysis using an antibody that recognizes BiP, Hsc70 and Hsp70 demonstrates that 
only wild-type CHIP, but not CHIP K30A, increases Hsp70 expression after adenoviral 
infection, whereas BiP levels are increased by tunicamycin (Tm) but not by CHIP. 
(B) Hsp70 promoter activity is increased by wild-type CHIP and by a mutant lacking 
ubiquitin ligase activity (CHIP D253N/R254G), but not by a mutant that does not 
interact with Hsp70/Hsp90 (CHIP K30A). 
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Chaperones (including protein phosphatase 5, FKBP59 and HOP, each of which contains 
TPR repeats), only CHIP increased Hsp70 expression (Figure 2.4A), and no co-chaperone 
other than CHIP significantly activated the Hsp70 promoter (Figure 2.4B). 
Several lines of evidence suggest that the induction of Hsp70 by CHIP is not a non-
specific stress response generated by increased concentration of misfolded proteins by CHIP 
overexpression. First, CHIP overexpression neither results in an increased amount of 
misfolded proteins by metabolic labeling (Meacham et al., 2001), nor inhibits general 
proteasome function (Jiang et al., 2001). Second, overexpression of CHIP, but not other co-
chaperones, induced expression of Hsp70. If we suspect that overexpression of proteins 
increases the amount of unfolded proteins, it is highly unlikely that only the overexpression 
of CHIP, but not that of the other co-chaperones, results in the induction of stress response. 
Third, we performed experiments to test whether overexpression of CHIP activates 
endoplasmic reticulum stress response. Compared with tunicamycin that activated a potent 
ER stress response manifested by the induction of BiP, overexpression of CHIP did not affect 
BiP levels (Figure 2.5A). Importantly, the inducibility of Hsp70 was completely abolished by 
a mutant form of CHIP (CHIP K30A). This mutant is expressed at similar levels to wild-type 
protein and differs only in a single amino acid residue in the TPR domain that abolishes 
interactions with Hsp70 (Scheufler C, 2000); thus, non-specific activation of the stress 
response by protein overexpression can be excluded. The specificity of this effect raised the 
question of which features of CHIP contribute to HSF1 activation. To address this, we tested 
the ability of CHIP mutants to activate the Hsp70 promoter in transient transfection assays. 
CHIP K30A is unable to activate Hsp70 promoter activity, whereas the activity of CHIP 
D253N/R254G (which contains mutations in the U-box that abolish ubiquitin ligase activity  
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Figure 2.6 Trimerization of HSF1 induced by CHIP overexpression. HSF1 
expression was examined by non-denaturing gel electrophoresis in COS7 cells after heat 
shock (42°C) or after infection with CHIP-expressing adenovirus (or a control 
adenovirus). Depletion of inactive complexes [which consist of dimers and Hsp70-
bound monomers (Liu and Thiele, 1999; Guo et al., 2001)] and quantitative 
accumulation of the activated trimeric form of HSF1 occurs in CHIP-expressing cells.  
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(Xu et al., 2002)) was equivalent to that of wild-type CHIP (Figure 2.5B). Thus, the TPR 
domain of CHIP that is required for the interaction with Hsp70 and Hsp90, but not the U-box 
that has E3 ligase activity, is required for the induction of Hsp70 by CHIP. 
Assembly of a CHIP-dependent activated HSF1 complex – Activation of HSF1 is a 
multi-step event that includes HSF1 derepression from Hsp70 or Hsp90, trimerization and 
nuclear localization, binding to HSE and becoming transcriptionally competent.  We have 
shown that activation of HSF1 by CHIP is accompanied by the binding of HSF1 to HSE by 
the gel shift assay (Figure 2.3A) and transcriptional competency of HSF1 by the reporter 
gene assays (Figure 2.2B and 2.5B). We then examined whether HSF1 became trimerized by 
CHIP overexpression. We used a conventional non-denaturing gel separation technique that 
allows discrimination of monomeric, dimeric, Hsp70-bound and trimeric HSF1 complexes 
(Zou et al., 1998; Liu and Thiele, 1999; Guo et al., 2001). As a positive control, heat shock 
induced trimerization of HSF1 peaked at 1 hour after the beginning of heat shock and 
persisted to 4 hours. CHIP overexpression also activated trimerization of HSF1. However, 
the kinetics of this trimerization was different from that triggered by heat shock. 
Trimerization of HSF1 was induced rapidly when overexpressed CHIP was first detectable at 
12 hours after transfection, and persisted for at least 48 hours (Figure 2.6, 2.8), suggesting 
that CHIP-induced trimeric HSF1 complexes may be resistant to attenuation. HSF1 trimers 
induced by CHIP overexpression had a slightly retarded mobility on PAGE gels, which 
suggests that posttranslational modification of HSF1 occurred during this process as after 
heat shock (Wu, 1995). Indeed we observed increased HSF1 phosphorylation by CHIP 
overexpression in our 32P labeling experiment (data not shown).  
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Figure 2.7 Both HSF1 and wild type CHIP, but not the K30A mutant, bind to 
Hsp70. COS7 cell lysates were prepared 24 h after infection with wild-type (WT) 
or CHIP or the K30A mutant (or a control adenovirus), and whole cell lysates 
(WCL) or immunoprecipitates (IP) were probed by western blotting for the 
presence of HSF1, Hsp70 and CHIP. (NS—non-specific band) 
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Figure 2.8 HSF1-Hsp70-CHIP form a trimeric complex that is 
transcriptionally active.  COS7 cells were infected with CHIP adenovirus for 
the indicated times and whole cell lysates or HSF1 immunoprecipitates were 
probed for HSF1, Hsp70 or CHIP. Hsp70 is stably associated with activated 
HSF1 in CHIP-expressing cells and CHIP could be precipitated with Hsp70 in 
these HSF1 immunoprecipitates. 
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Several studies have demonstrated that both Hsp70 and Hsp90 can repress transcriptional 
activation of HSF1 (Rabindran et al., 1994; Shi et al., 1998; Zou et al., 1998). Since CHIP 
interacts with Hsp70/Hsp90, one possible explanation for CHIP-dependent activation of 
HSF1 is that CHIP disrupts Hsp/HSF1 complexes and thus induces de-repression of HSF1 by 
Hsp70 or Hsp90. To test this, we examined the effects of CHIP expression on these 
interactions by co-immunoprecipitation assays. Hsp90/HSF1 interactions remained below the 
limits of our detection either with or without crosslinkers. However, when we used Hsp70 
antibody to precipitate Hsp70 containing complexes, in contrast to the expectation that CHIP 
would disrupt HSF1/Hsp70 complexes, we detected a weak interaction between Hsp70 and 
HSF1 in cells expressing GFP control, but a very strong interaction between the two proteins 
when CHIP is overexpressed (Figure 2.7). These interactions were abolished by mutation of 
CHIP’s TPR domain, suggesting that this HSF1/Hsp70 complex required interactions 
between CHIP and Hsp70 (Figure 2.7). We also found that when activated HSF1 was co-
immunoprecipitated by Hsp70, CHIP was co-immunoprecipitated simultaneously. Since we 
have not detected direct interaction between CHIP and HSF1, there are two possibilities of 
these interactions. First, there are two independent complexes, the Hsp70/HSF1 and the 
Hsp70/CHIP complexes; and second, different domains of Hsp70 establish interactions with 
HSF1 and CHIP independently and thus these three proteins form a trimeric complex. To test 
the two possibilities, we performed a converse experiment. We used HSF1 antibody to 
perform the co-IP experiment. We found that CHIP and Hsp70 were both present in HSF1 
immunoprecipitates (Figure 2.8), and the stability of these complexes was similar to that of 
CHIP-dependent HSF1 trimerization (Figure 2.6). Therefore these results indicate that CHIP,  
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Figure 2.9 Induction of Hsp70 is reduced in CHIP (-/-) fibroblasts 
after heat shock. Western blot analysis of CHIP (+/+) or CHIP (-/-) 
fibroblasts after heat shock (HS) at 42°C for the indicated times.  
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Hsp70 and activated HSF1 exist in an Hsp70-dependent ternary complex that resists HSF1 
inactivation.  
 So far we have shown that CHIP overexpression influences several key steps involved 
in HSF1 activation. CHIP induces trimerization (Figure 2.6), heat shock protein promoter 
binding (Figure 2.3A), and transcriptional competency of HSF1 (Figure 2.2D). This activated 
HSF1 forms a stable trimeric complex with Hsp70 and CHIP that resists attenuation (Figure 
2.8), which suggests a mechanism for CHIP dependent HSF1 activation. Activation of heat 
shock factor and induction of Hsp70 argues for a previously unanticipated role for CHIP in 
modulating the stress response. Whether this function is significant at the levels of 
endogenous proteins need to be addressed.  
CHIP is required for maximal Hsp70 induction and protection against stress-
induced apoptosis -- We isolated dermal fibroblasts from CHIP (–/–) mice or wild-type 
littermates to address the role of endogenous CHIP in regulation of stress response pathways 
more directly. CHIP (–/–) fibroblasts had typical morphologic, growth rate and viability 
characteristics under standard culture conditions (37°C). However, in comparison with wild-
type fibroblasts, CHIP (–/–) fibroblasts exhibited markedly diminished responses to stress. 
We examined Hsp70 induction of these cells after heat shock (42°C) and found that the 
ability of Hsp70 to be induced was reduced by 50–60% in CHIP (–/–) fibroblasts 
(Figure 2.9A). This finding is consistent with our overexpression studies (Figure 2.1B), and 
also similar to that which occurs in HSF1-null cells (McMillan et al., 1998). Since Hsp70 
induction is crucial during heat shock response to protect cells from injury, we then tested if 
CHIP (–/–) fibroblasts had diminished survival after lethal heat shock (45°C). Indeed, 
viability of cells measured by XTT metabolism started to decrease in CHIP (–/–) fibroblasts  
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Figure 2.10 Impaired stress response and increased apoptosis in CHIP-deficient 
fibroblasts. (A). The decrease in viability is associated with increased accumulation of 
oligonucleosomes during recovery from heat shock (45°C for 45 min) for the indicated times as 
a marker of apoptosis (B). (C) CHIP (-/-) cells are also sensitive to challenge with L-
canavanine, an amino acid analog that causes accumulation of misfolded proteins 
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after 40 minutes of heat shock, with the maximum effect reaching 25% survival after 60 
minutes of heat shock; while the survival of CHIP (+/+) fibroblasts remained largely 
unchanged (Figure 2.10A). Since heat stress can activate an apoptotic cascade (Beere and 
Green, 2001), we then examined whether the reduced survival of CHIP (–/–) fibroblasts after 
heat shock was due to apoptosis. We measured oligonucleosomes formation as an indicator 
of apoptosis of cells after 60 minutes of heat shock at 45°C, and found that oligonucleosomes 
began to be detected 1 hour after heat shock in CHIP (–/–) fibroblasts, and the amount 
steadily increased to 4 hours after heat shock; while no oligonucleosomes were detected in 
CHIP (+/+) fibroblasts (Figure 2.10B).  The stress-induced defect in CHIP (–/–) fibroblasts 
was not limited to a failure of tolerance to heat shock; cells lacking endogenous CHIP were 
also more susceptible to L-canavanine, which is an arginine analog that incorporates into 
proteins during synthesis and induces protein misfolding. Viability of cells treated with L-
canavanine decreases in both the CHIP (+/+) and CHIP (–/–) fibroblasts, but the effect in the 
CHIP (–/–) fibroblasts was more profound (Figure 2.10C). As the primary defect in HSF1 (–
/–) fibroblasts is inability to develop thermotolerance after preconditioning with a sublethal 
heat challenge (42°C) (McMillan et al., 1998), we then examined whether CHIP (–/–) cells 
develop thermotolerance, thus sharing the same pathway that lead to induction of Hsp70. We 
measured cell viability at 6 hours or 24 hours after lethal heat shock. At the 6 hours recovery 
time point, viability of CHIP (–/–) fibroblasts was lower than that of CHIP (+/+) fibroblasts 
under the same treatments. In CHIP (–/–) fibroblasts, preconditioning increased cell viability 
from 50% to about 75%. Thus, the loss of viability of CHIP (–/–) cells after thermal 
challenge was partially rescued by preconditioning (Figure 2.11A). This suggested to us that 
CHIP may share a similar mechanism with HSF1 in the development of
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Figure 2.11 Preconditioning partially rescues CHIP (-/-) fibroblasts from 
lethal thermal challenges. (A and B) CHIP (-/-) and CHIP (+/+) cells were heat 
shocked for 45 min at 45°C 6 hours after with or without preconditioning at 42°C 
for 30 min. Viability of cells was measured after 6 h (A) or 24 h (B) of recovery at 
37°C as indicated. CHIP (-/-) fibroblasts suffer decrements in viability in the 
presence or absence of preconditioning. NS, without heat stress. 
A 
B 
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Figure 2.12 Caspase 3 is activated in CHIP (-/-) fibroblasts after 
heat shock. Caspase 3 activity (A) and cleaved caspase 3 levels (B) 
were measured using a colorimetric assay after thermal challenge (HS) 
with or without thermal preconditioning (PRE), as indicated. 
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thermotolerance. We measured caspase 3 activity after thermal stress with or without 
preconditioning as a biochemical marker of apoptosis. In comparison to wild-type cells, 
CHIP (–/–) cells markedly increased caspase 3 activity following thermal challenge at 45°C, 
and this increase is only modestly reduced by preconditioning (Figure 2.12A). Similarly, 
cleaved (and therefore activated) caspase 3 is only detected in CHIP (–/–) cells after heat 
shock, with or without preconditioning (Figure 2.12B). These studies of the functions of 
endogenous CHIP support our interpretation of CHIP overexpression studies, and indicate 
that CHIP has an unanticipated central role in regulating the cellular response to stress. 
2.5 Discussion 
In the present study, we demonstrate that the Hsp70/Hsp90 co-chaperone CHIP is an 
activator of HSF1 that leads to the induction of heat shock proteins, which is characteristic of 
heat shock response. Our conclusion is supported by three lines of evidences. First, 
overexpression of CHIP induces trimerization, HSE binding, transcriptional activation of 
HSF1, which results in transcription of heat shock proteins 70, 90, and 27. Second, CHIP-
Hsp70-HSF1 forms a stable transcriptional active complex on HSE that resists attenuation. 
Third, in cell lines without expression of endogenous CHIP, there is decreased levels of heat 
shock response, which is associated with decreased viability and increased apoptosis at times 
of stress challenges. These results indicate that CHIP is an important regulator of heat shock 
response. 
The prevailing model suggests that Hsp70 and Hsp90 are negative regulators of HSF1. 
These heat shock proteins are induced during heat shock response and forms a feed back 
control of HSF1 that leads to repression of HSF1 and attenuation of heat shock response 
(Morimoto, 1998). However, this model is complicated by the fact that Hsp70 also interacts 
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with transcriptionally active, HSE bound HSF1 [(Abravaya et al., 1992; Rabindran et al., 
1994) and our own observation], and HSF1-bound Hsp70 has little effect on transcriptional 
activity during the activation phase. Our studies here demonstrate that an additional HSF1–
chaperone complex can assemble in the presence of CHIP and that this complex maintains a 
stably activated form of HSF1 that resists attenuation. Interaction between Hsp70 and HSF1 
is mediated by the binding of substrate binding domain of Hsp70 with the transactivation 
domain of HSF1, which has the feature of substrate-chaperone complex (Shi et al., 1998). 
Formation of the CHIP-Hsp70-HSF1 trimeric complex requires the TPR domain of CHIP 
(Figure 2.7), indicating that interaction of the TPR domain of CHIP with the carboxyl 
terminal EEVD motif of Hsp70 is involved. In case of CHIP-Hsp70-HSF1 trimeric complex, 
it is plausible that modulation of the ATPase activity or the substrate binding affinity of 
Hsp70 by CHIP (Ballinger et al., 1999) causes remodeling of the interaction between Hsp70 
and HSF1 and subsequent exposure of the transactivation domain of HSF1, leading to 
sustained transcriptional activation of HSF1. In any event, the activation of HSF1 by CHIP 
represents another layer of regulation, in addition to that conferred by Hsp70 or Hsp90 alone, 
for controlling the effects of HSF1, and markedly contrasts with other co-chaperones tested in 
this context, which universally repress HSF1 (Rabindran et al., 1994; Nair et al., 1996; Shi et 
al., 1998; Zou et al., 1998; Bharadwaj et al., 1999; Marchler and Wu, 2001). Recently, Daxx, 
a nuclear protein, has also been suggested to be a positive regulator of HSF1. Daxx cannot 
initiate the activation of HSF1, but interacts with trimeric HSF1 and is required for its 
maximum activation (Boellmann et al., 2004). These additional regulations may be necessary 
to fine-tune the stress response, especially in cells where protein levels or activities of these 
regulatory factors are under control. Examples of these cells in which CHIP levels are 
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controlled are metabolically active tissues such as striated muscle (Ballinger et al., 1999) or 
after proteasome inhibition (Imai et al., 2002). 
CHIP was originally identified as an Hsp70 co-chaperone that inhibits the ATPase 
activity of Hsp70 and thus induces substrate release from Hsp70 and the inhibition of Hsp70 
refolding activity in vitro (Ballinger et al., 1999). Subsequently, the U-box of CHIP was 
found to contain ubiquitin E3 ligase activity and that it ubiquitylates chaperone substrates 
and sends them to the proteasome for degradation (Hohfeld et al., 2001; McClellan and 
Frydman, 2001). A global switching of a chaperone substrate off the refolding pathway and a 
diversion of chaperone substrates to the proteasome for degradation are enormous burdens 
for the cells to bear, since partially damaged proteins that are otherwise able to regain their 
native structure and function are degraded, and thus a significant amount of energy that was 
consumed to synthesize these proteins is wasted. Our finding that CHIP also activates HSF1 
and induces the expression of Hsp70, as well as another report that CHIP increases the 
Hsp70-dependent folding activity within cells (Kampinga et al., 2003), suggests that CHIP 
increases the total buffering and folding capacity of the cell. The simultaneous enhancement 
of folding of reversibly damaged proteins and degradation of irreversibly damaged chaperone 
substrates may account for the cytoprotective effect of CHIP during stress challenges.  
Regulation of the apoptotic pathway is part of regulation of the stress response. 
Molecular chaperones, especially Hsp70, intervene with multiple levels of the apoptotic 
pathways to exert their anti-apoptotic function (Beere and Green, 2001). In this study, we 
found that CHIP protected cells from heat shock induced apoptosis. It is conceivable that this 
anti-apoptotic activity of CHIP is mediated by activation of HSF1 and induction of Hsp70, as 
well as by enhanced degradation of chaperone substrates. Subsequent studies suggest that 
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CHIP polyubiquitylates and degrades proapoptotic proteins ASK1 (Apoptosis signal-
regulating kinase 1) (Hwang et al., 2005) and p53 (Esser et al., 2005; Hwang et al., 2005). 
Therefore, the effects of CHIP on both the global stress response and specific apoptotic 
pathways account for the overall antiapoptotic function of CHIP. 
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3.1 Abstract 
The cytoplasm is protected against the perils of protein misfolding by two mechanisms: 
molecular chaperones, which facilitate proper folding, and the ubiquitin-proteasome system, 
which regulates degradation of misfolded proteins. CHIP (carboxyl terminus of Hsp70-
interacting protein) is an Hsp70-associated ubiquitin ligase that participates in this process by 
ubiquitylating misfolded proteins associated with cytoplasmic chaperones. Mechanisms that 
regulate the activity of CHIP are, at present, poorly understood. Using a proteomics 
approach, we have identified BAG2, a previously uncharacterized BAG domain-containing 
protein, as a common component of CHIP holocomplexes in vivo. Binding assays indicate 
that BAG2 associates with CHIP as part of a ternary complex with Hsc70. In vitro and in 
vivo ubiquitylation assays indicate that BAG2 is an efficient and specific inhibitor of CHIP-
dependent ubiquitin ligase activity. This activity is due, in part, to inhibition of interactions 
between CHIP and its cognate ubiquitin-conjugating enzyme, UbcH5a, which may in turn be 
facilitated by ATP-dependent remodeling of the BAG2-Hsc70-CHIP heterocomplex. The 
association of BAG2 with CHIP provides a cochaperone-dependent regulatory mechanism 
for preventing unregulated ubiquitylation of misfolded proteins by CHIP.  
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3.2 Introduction 
Cells are the basic building blocks of living organisms and proteins are structural and 
functional elements of the cell. Integrity of proteins is constantly under challenges of 
oxidative, chemical and thermal damages. Cells have evolved a sophisticated protein quality 
control system to maintain protein homeostasis. This system includes the molecular 
chaperone system that helps to fold or refold partially damaged proteins, and the ubiquitin 
proteasome system in the eukaryotic cells to degrade irreversibly damaged proteins. 
Improper protein quality control leads to disturbance of normal cellular functions, and results 
in a variety of diseases (Wickner et al., 1999).  
A “protein triage” model has been proposed that defines partitioning of nonnative 
proteins between chaperones and the proteasome, although it is not completely clear how 
decision is made (Wickner et al., 1999). Recently, the co-chaperone/ubiquitin ligase CHIP 
(carboxyl terminus of Hsp70-interacting proteins) has been implicated in both the protein 
refolding and degradation pathways. CHIP activates HSF1 (Dai et al., 2003) and increased 
Hsp70 folding activity of the cells (Kampinga et al., 2003) ; the U-box of CHIP also has E3 
ubiquitin ligase activity (Jiang et al., 2001) that ubiquitylates a variety of chaperone-bound 
cytoplasmic and membrane proteins (Connell et al., 2001; Meacham et al., 2001; Xu et al., 
2002). Substrates of CHIP are generally categorized into two groups, which include 
aggregation-prone proteins that need chaperones during their maturation, such as Hsp70 
bound immature CFTR (Meacham et al., 2001), Hsp90 clients ErbB2 (Xu et al., 2002) and 
glucocorticoid receptor (Connell et al., 2001), and nonnative misfolded proteins that are 
captured by cytoplasmic chaperones (Murata et al., 2001; Yaguchi et al., 2004). Thus CHIP 
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promotes both the folding and degradation pathways of the protein quality control system, 
making CHIP a candidate for regulation of protein triage decision making. 
CHIP is constitutively expressed in metabolically active tissues (Ballinger et al., 1999), 
and protein levels of CHIP are largely unchanged during stress challenges, except one 
observation of increased CHIP level after proteasome inhibitor treatment of a neuronal cell 
line (Imai et al., 2002), leaving regulation of CHIP activity more pertinent. CHIP forms 
homodimers and dimerization is required for its E3 ubiquitin ligase activity by truncation 
mutation experiments in vitro (Nikolay et al., 2004). Besides that, it is unclear how the 
activity of CHIP is restrained so that unnecessary ubiquitylation of chaperone substrates is 
avoided. To gain a better understanding of regulation of CHIP in protein quality control 
network, we took an inductive approach to identify the components of endogenous CHIP 
complexes using mass spectrometry. We have found that BAG2 is present in the cytoplasmic 
chaperone complexes that contain CHIP. BAG2 inhibits CHIP ubiquitin ligase activity by 
disrupting CHIP-Hsp70 ubiquitin ligase complex and also by interfering with CHIP-E2 
ubiquitin conjugase association.  
3.3 Materials and methods 
Antibodies -- Rabbit polyclonal anti-CHIP and anti-BAG2 antibodies were described 
previously (Ballinger et al., 1999). Rabbit polyclonal anti-Hsc70 (SPA 816) was from 
Stressgen. Mouse anti-CHIP monoclonal antibody (colony 67) was produced in collaboration 
with the UNC Monoclonal Antibody Core Facility. Mouse CFTR R domain-specific 
antibody (MAB1660) was from R&D systems and the MM13-4 anti-CFTR antibody was 
from Upstate. Anti-Rat-FITC and anti-mouse Texas Red fluorescent antibodies were from 
Molecular Probes.  
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Cell culture and transfection -- To generate stable transfectants, pcDNA3-Myc-CHIP 
or pcDNA3 alone were transfected into HeLa cells cultured on 100-mm plates. 48 hours after 
transfection, cells were split and G418 was added at a working concentration of 400 µg/ml. 
Two weeks after transfection, G418-resistant colonies with isolated with cloning rings and 
screened for expression by Western blotting. For transient transfections, HEK293 cells were 
transfected with equivalent concentrations of CFTR∆F508, CHIP and BAG2 plasmids using 
Effectene (Qiagen) at the DNA:Effectene ratio of 1:5. Cells were lysed with RIPA buffer 24 
hours after transfection, and CFTR protein levels were analyzed by SDS-PAGE followed by 
Western blotting. 
Mass spectrometry detection of CHIP associated proteins -- HeLa cells stably 
expressing Myc-CHIP were cultured in 150-mm plates to confluence. Cells were lysed with 
RIPA buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EGTA, 0.25% sodium 
deoxycholate, 1% NP-40 and 1 mM sodium orthovanadate). Anti-Myc agarose (9E10, Santa 
Cruz Biotechnology) was added to the cell lysates. Agarose beads were then spun down at 
500X g for 3 minutes and washed 5 times with RIPA buffer. 2X SDS sample buffer was 
added to the beads and boiled. After pulse spinning, the supernatants were loaded onto SDS-
PAGE. Silver staining was performed using the Invitrogen SilverQuest kit according to 
standard instructions. Individual gel bands were excised according to protocols described 
previously (Borchers et al., 2000), and the proteins were in-gel digested and analyzed by 
combined mass spectrometric approaches. Briefly, the gels were subjected to trypsin 
proteolysis using a ProGest automated digester (Genomics Solutions). The extracted peptides 
were analyzed on a MALDI-TOF/TOF (Applied Biosystems) and an ESI Q-TOF (API-US 
Micromass) equipped with a capillary LC system from Waters. Data were submitted to the 
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MASCOT database search engine (MatrixScience) for protein identification by peptide mass 
fingerprinting and sequence tag approaches.  
Preparation of expression constructs -- pGEX-4T-1 BAG2 was previously described 
(Takayama and Reed, 2001). Full length BAG2 was subcloned into pcDNA3-HA for 
mammalian expression. PCR was performed to generate BAG2 4-90 and 91-211 fragments 
and cloned into pcDNA3-HA and pGEX-6P-1. His-Hsc70, Myc-CHIP and GST-CHIP 
plasmids were described previously (Ballinger et al., 1999).  
Protein purification -- Recombinant proteins were produced in BL21(DE3)RP cells 
(Stratagene). The cells were induced with 0.4 mM IPTG at room temperature for 5 hours. 
The cultures were spun down at 4ºC, dissolved in GST lysis buffer (20mM Tris, pH 8.0, 300 
mM NaCl, 2 mM EDTA and 2 mM DTT), sonicated, and cleared by centrifugation. 
Supernatants were incubated with glutathione-sepharose 4B beads at 4ºC for 2 hours and 
washed with GST lysis buffer with 0.5% Triton 4 times. In some experiments, the GST tag 
was cleaved with Precision protease (Amersham Biosciences) for pGEX-6P-1 constructs or 
thrombin for PGEX-4T-1 constructs. For purification of His-Hsc70, bacterial cultures were 
lysed in His-lysis buffer (50 mM Tris, pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05% β-
ME, and 1 mM benzamidine), and purified with Ni-NTAagarose beads (Qiagen). 
Recombinant NBD1-R, CHIP, Hsp70, Hdj2, and UbcH5a were purified as previously 
described (Younger et al., 2004).  
In vitro ubiquitylation reactions -- In vitro ubiquitylation of CFTR NBD1-R domain 
was performed as described previously (Younger et al., 2004). Briefly, 0.5 µg of purified 
CFTR-NBD domain was incubated with 4 µM CHIP, 0.4-20 µM BAG1 or BAG2, 2 µM 
Hsp70, 4 µM Hdj2, 0.3 µg purified rabbit E1 (Calbiochem), 1 mg/ml ubiquitin (Sigma), and 
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8 µM UbcH4 in 20 mM HEPES, pH 7.2, 100 mM KCl, 5 mM MgCl2, 5 mM ATP, 10 mM 
dithiothreitol for 3 h at 37 °C. Samples were analyzed by SDS-PAGE and blotted with anti-
CFTR R domain or anti-Hsp70 antibodies.  
Nucleotide binding assays -- Measurement of nucleotide species bound to Hsp70, 
CHIP, or BAG2 was performed by [α-32P]8-N3ATP photolabeling. 0.5 µg of BSA, 0.3 µg 
of CHIP, 0.4 µg of BAG2, or 0.5 µg of Hsp70 (to keep equimolar amounts of proteins in 
each reaction) were incubated with 1 µCi of [α-32P]8-N3ATP (10-15 Ci/mmol) in 20 µl of 
reaction buffer containing 20 mM Hepes, pH 7.4, 50 mM KCl, and 10 mM MgCl2. After 15 
minutes incubation at room temperature, the reactions were irradiated with an ultraviolet 
transilluminator for 2 minutes. Nucleotides bound to proteins were then separated from the 
free nucleotides by size exclusion chromatography using a G50 spin column. 1 µl of the flow 
through were analyzed by liquid scintillation counting.  
GST pull-down assays -- Glutathione-sepharose bound proteins were incubated with 
purified proteins for 2 hours at 4ºC with continuous rotation in GST lysis buffer. The beads 
were washed 4 times with GST lysis buffer containing 400 mM NaCl. Beads were then 
boiled in 1X SDS sample buffer and loaded on SDS-PAGE. For His-Hsc70 binding assays, 
binding reactions were performed in His-lysis buffer with purified BAG2 and CHIP. When 
indicated, some experiments were performed in the absence or presence of ATP, ADP, or the 
non-hydrolyzable ATP analogAMP-PNP (5 mM).  
3.4 Results 
Identification of CHIP-associated proteins by mass spectrometry – In order to 
analyze the endogenous CHIP-containing protein complexes, we created  a HeLa cell line  
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Figure 3.1 Mass spectrometry identification of BAG2 as a component of CHIP-
containing complexes in vivo. A. HeLa cell lines were stably transfected with a plasmid 
containing Myc-tagged CHIP or vector alone. Clones expressing Myc-CHIP at near-
endogenous levels, as confirmed by Western blot analysis, were selected and used to 
identify endogenous proteins present in CHIP complexes in vivo. B. Silver staining of 
input (In), flowthrough (Ft), and Myc immunoprecipitates (IP) from these HeLa cell 
lines indicates the proteins that co-purify with CHIP. A 26-kDa protein was sequenced 
by mass spectrometry, and the 6 indicated peptide sequences were identified which led 
to the conclusion that this protein was BAG2. 
 75
 
Figure 3.2 Western blotting confirmed BAG2 as a component of CHIP-
containing complexes. Western blot analysis with antibodies against 
Hsp/Hsc70, CHIP, and BAG2 confirmed the identities of these proteins in 
immunoprecipitates from Myc-CHIP-expressing cells. 
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that stably expresses Myc-tagged CHIP at levels approximating endogenous expression, and 
a cell line that is transfected with the parent vector alone (Figure 3.1A). Low-level expression 
of the transgene avoided CHIP-dependent activation of heat shock factor-1 (Dai et al., 2003), 
and also enabled us to detect the complexes that were similar to the endogenous CHIP-
containing complexes. Lysates from these cell lines were probed with an anti-Myc 
monoclonal antibody, and immunocomplexes were resolved by electrophoresis followed by 
silver staining to detect individual components. Representative immunocomplexes are shown 
in Figure 3.1B. Individual bands were excised and analyzed by MALDI TOF/TOF and ESI 
Q-TOF (Borchers et al., 2000). Consistent with previous observations, peptides representing 
Hsc/Hsp70 and CHIP were identified in bands of the appropriate molecular weights, 
indicating that CHIP associates with chaperones and homodimerizes (Ballinger et al., 1999; 
Nikolay et al., 2004). In addition, a 28-kDa band that was present in approximate 
stoichiometry with Hsc70 in CHIP immunocomplexes was identified. 6/6 resolvable spectra 
coded fragments of BAG2. We further confirmed the identity of this band by using an anti-
BAG2 antibody and we found this protein was enriched in CHIP-containing 
immunocomplexes (Figure 3.2).  
BAG2 is one of six proteins in mammalian cells that contain the BAG domain. BAG1, 
the founding member of this family, was originally identified as a Bcl-2-binding protein. 
Subsequently it was confirmed to associate with Hsc70 as a co-chaperone (Takayama S, 
1995; Takayama et al., 1997). All the BAG domains of the BAG family proteins are located 
in the C-terminus of these proteins, and are able to interact with the ATPase domain of 
Hsp70 (Takayama et al., 1999). This interaction induces a conformational change of the 
ATPase domain, which results in nucleotide exchange (Sondermann et al., 2001). In addition  
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Figure 3.3 GST-CHIP pulls down BAG2 via Hsp70 in vitro. In vitro pull-
down assays with GST-CHIP (or GST alone) were used to test the 
associations of CHIP with BAG2 in the presence or absence of Hsp70. In 
these assays, CHIP efficiently interacted with BAG2, but only when Hsp70 
was present in the binding assays. 
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Figure 3.4 BAG domain of GST-BAG2 pulls down CHIP via Hsp70 in vitro. 
In vitro binding of recombinant CHIP and Hsp70 with full-length GST-BAG2 or 
BAG2 fragments containing amino acids 4-90 or 91-211 (BAG domain) was 
tested in GST pull-down assays. In these assays, BAG domain of BAG2 pulls 
down CHIP with a much less efficiency compared with full-length BAG2 in the 
presence of Hsp70. 
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Figure 3.5 His-Hsc70 pulls down CHIP and BAG2 without competition 
in vitro. Associations of proteins with Hsc70 (tagged with His), with or 
without BAG2 and/or CHIP, were tested in binding assays using 
immobilized nickel. In these assays, both CHIP and BAG2 associated with 
Hsc70 independently, and their association with Hsc70 was not competitive 
when both CHIP and BAG2 were present. 
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Figure 3.6 Interaction of CHIP with BAG2 requires the TPR domain of CHIP in 
HeLa cells. HeLa cells were co-transfected with HA-BAG2 and different truncation 
mutants of Myc-CHIP. Co-immunoprecipitation were performed using anti-Myc 
antibody and Western blotting were used to detected CHIP and BAG2 in these 
immunocomplexes. Wild type CHIP and CHIP∆U box pulled down HA-BAG2 with 
equal affinity, while CHIP∆TPR could not pull down HA-BAG2.  
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to the BAG domains, BAG-family proteins also contain a diversity of domains, which allow 
them to interact with specific target proteins or which target them to specific locations within 
cells (Takayama and Reed, 2001). BAG2 contains the most divergent BAG domain among 
this family at its carboxyl terminus, and the 90 amino-proximal residues contain no motifs 
except for coiled-coil structure recognized by the SMART and PFAM algorithms. No 
cellular functions have been assigned to this protein to date. Interestingly, BAG1 has been 
implicated in CHIP-dependent protein degradation (Demand et al., 2001), although we did 
not discover BAG1 in these experiments nor in other tests for endogenous CHIP interaction 
partners (data not shown). 
Next, we used in vitro binding assays with purified proteins to verify and characterize 
the observed interaction between CHIP and BAG2. When we used GST-CHIP, we could 
only pull-down BAG2 in the presence of Hsp70 (Figure 3.3). In a converse experiment, 
GST-BAG2 precipitated CHIP in an Hsp70-dependent fashion (Figure 3.4). Deletions of 
either the BAG domain (amino acids 91-211) or the amino terminal extension (amino acids 
4-90) revealed that the BAG domain recruited both Hsp70 and CHIP, but with markedly 
lower efficiency than native BAG2, suggesting an additional role for the BAG2 amino 
terminus in efficient complex assembly. Finally, we used nickel chromatography to isolate 
recombinant proteins associated with His-tagged Hsc70. Both CHIP and BAG2 bound Hsc70 
efficiently and without competition (Figure 3.5). For reasons discussed below, it is important 
to note that the preceding experiments were done in the absence of ATP. To examine 
domains of CHIP required in the complex formation, we transfected HeLa cells with HA-
BAG2 and different truncation mutants of Myc-CHIP. We found that HA-BAG2 could be 
efficiently pulled-down by wild type and U-box deletion mutant, but not the TPR domain  
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Figure 3.7 Inhibition of CHIP ubiquitin ligase activity by BAG2. A. In vitro 
ubiquitylation assays were performed in reactions containing E1, UbcH5a, CHIP, 
Hsp70, HDJ2, and the indicated molar ratios of BAG2 to CHIP. The NBD1-R domain 
of CFTR served as a substrate in these reactions. Western blotting for NBD1 was used 
to identify its ubiquitylated forms. B. Similar in vitro reactions were performed with 
Hsp70 as the substrate. 
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Figure 3.8 Comparison of BAG2 with BAG1 in their ability to inhibit 
CHIP ubiquitin ligase activity. The antiubiquitylation activities of BAG1 and 
BAG2 were compared in in vitro ubiquitylation assays using CFTR NBD1-R 
as a substrate. Ten-fold higher concentration of BAG1 compared with BAG2 
was required to achieve similar inhibitory effects. 
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deletion mutant (Figure 3.6) , which cannot associate with Hsc/Hsp70 (Ballinger et al., 
1999). These results, together with previous observations (Takayama and Reed, 2001), 
suggest Hsp70 acts as a bridge that brings BAG2 and CHIP into a trimeric protein complex, 
with its ATPase domain interacting with BAG domain of BAG2 and its carboxyl terminal 
EEVD motif interacting with TPR domain of CHIP, respectively. This complex appears to be 
further stabilized by interactions involving the amino terminus of BAG2 binding to other 
sites within this complex; these interactions were explored further in subsequent studies (see 
below). 
BAG2 inhibits the ubiquitin ligase activity of CHIP -- CHIP regulates both arms of 
the cytoplasmic quality control: CHIP directly activates heat shock factor-1 (which 
transcriptionally regulates molecular chaperones) (Dai et al., 2003) and increases the folding 
capacity of the cells (Kampinga et al., 2003), and CHIP is a chaperone-dependent ubiquitin 
ligase (Jiang et al., 2001) that selectively degrades chaperone substrates. Using a variety of 
assays, we did not identify any consistent effects of BAG2 on CHIP dependent heat shock 
factor-1 activation (data not shown). However, when we used a well-defined CHIP 
substrate—NBD1 domain of CFTR—to test the ubiquitin ligase activity of CHIP, we found 
that activity of CHIP was efficiently inhibited by BAG2 (Figure 3.7). Half-maximal effects 
of BAG2 occurred at roughly stoichiometric concentrations of BAG2 relative to CHIP. We 
detected ubiquitylation of Hsp70 since it is also a substrate of CHIP (Jiang et al., 2001), and 
found that addition of ubiquitin residues to this protein is inhibited in a degree similar to that 
of NBD1 (Figure 3.7B).  
To distinguish whether the inhibition of CHIP E3 ligase activity is specific to BAG2 or 
general to all BAG domain containing proteins, and to compare the activity of BAG2 with 
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BAG1 since BAG1 has been placed in complexes with CHIP in in vitro studies (Demand et 
al., 2001), we performed in vitro NBD1 ubiquitylation assays with increasing dose of BAG2 
or BAG1. Even at 10-fold higher molar ratio compared with BAG2, BAG1 had negligible 
effects on CHIP ubiquitin ligase activity (Figure 3.8). These results are consistent with 
previous finding that BAG1 does not affect E3 ligase activity of CHIP (Demand et al., 2001), 
and indicate that the presence of a BAG domain alone is insufficient to inhibit CHIP activity. 
In addition, these experiments confirm the specificity of BAG2 as an inhibitor of CHIP 
ubiquitin ligase activity in this assay.  
BAG2-dependent remodeling of the CHIP ubiquitin ligase complex – To explore 
the mechanism of BAG2-dependent inhibition of CHIP ubiquitin ligase activity, we 
considered several possible regulatory points that can be utilized by BAG2, based on our 
current understanding of CHIP activity. First, CHIP forms homodimers and dimerization is 
required for its ubiquitin ligase activity (Nikolay et al., 2004). Therefore, manipulation of 
dimeric states of CHIP is a possible candidate. Second, CHIP-Hsp70 forms an E3 ubiquitin 
ligase complex so that U-box of CHIP brings ubiquitin charged E2 ubiquitin conjugase, and 
the substrate binding domain of Hsp70 brings ubiquitylation substrates. Since BAG2 is a 
nucleotide exchange factor for Hsp70 that induces substrate release, it could be the 
mechanism of BAG2 dependent inhibition. However, CHIP dependent ubiquitylation of 
Hsp70 is inhibited by BAG2, making it less likely that release of Hsp70 substrates accounts 
for the inhibition of E3 ligase activity by BAG2. It is also possible that BAG2 disrupts 
Hsp70-CHIP or CHIP-E2 interaction. 
To test whether BAG2 disrupted CHIP homodimers, we co-expressed both Myc and 
FLAG-tagged CHIP in cultured cells and used the different tags to assay CHIP dimerization 
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Figure 3.9 BAG2 does not disrupt CHIP dimers. Vectors expressing Flag- 
and Myc-tagged CHIP (1 µg each) were co-transfected in HeLa cells along 
with increasing concentrations of a plasmid expressing HA-tagged BAG2 (1-
5 µg). Cell lysates were immunoprecipitated with an anti-Myc antibody and 
then blotted to detect Flag-CHIP and HA-BAG2 that associated with Myc-
CHIP in vivo. 
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Figure 3.10 Nucleotide dependent remodeling of CHIP-Hsp70-BAG2 
complexes. GST-BAG2, Hsp70 and CHIP were preassembled into complexes in 
different combinations for 30 min and then incubated with ATP, ADP, or the non-
hydrolyzable ATP analog AMP-PNP. BAG2-containing complexes were then 
precipitated with glutathione-sepharose and Western blotting was performed to 
detect Hsp70 and CHIP in these complexes. 
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Figure 3.11 Dissociation of Hsp70 and CHIP by BAG2 in the presence of 
ATP. A and B. In vitro binding reactions containing 4 µM CHIP, 2 µM Hsp70, 
4 µM Hdj2, 0.3 µg purified rabbit E1, 1 mg/ml ubiquitin, 8 µM UbcH4, and the 
indicated molar ratios of BAG1 (A.) or BAG2 (B.) were performed in 20 mM 
HEPES, pH 7.2, 100 mM KCl, 5 mM MgCl2, 5 mM ATP, 10 mM dithiothreitol. 
Hsp70 immunocomplexes were precipitated and blotted for the presence of 
CHIP and BAG2. 
A 
B 
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 by coimmunoprecipitation. CHIP dimers were easily detected under these conditions, and 
BAG2 readily incorporated into complexes containing these dimers, but (even at saturating 
levels of BAG2 expression) CHIP dimerization was not affected (Figure 3.9).  
Formation of Hsp70-containig protein complex is dependent on nucleotide binding, so 
we next examined the nucleotide dependence of the association of BAG2 and Hsp70 with 
CHIP. We observed that addition of adenine nucleotide induced release of Hsp70 from 
preformed CHIP-Hsp70-BAG2 complexes by GST-BAG2 pull-down assays; however, 
association of CHIP with BAG2 was retained in the presence of ATP but not ADP or the 
non-hydrolyzable ATP analog AMP-PNP, indicating that CHIP and BAG2 associated 
directly under this condition. This conclusion was supported by the experiment with 
incubation of BAG2 and CHIP only, which showed direct binding of BAG2 and CHIP in the 
presence of ATP (Figure 3.10). The release of Hsp70 from BAG2-CHIP complexes in the 
presence of ATP, as indicated in Figure 3.10, suggested that one mechanism to account for 
inhibition of CHIP by BAG2 is through dissociation of Hsp70 that is required for substrate 
presentation to CHIP. We therefore performed additional binding assays under the same 
conditions as our in vitro ubiquitylation reactions (Figure 3.11) in an ATP-containing system. 
Under these conditions, and in contrast to the effects observed in the absence of ATP (Figure 
3.3-3.5), BAG2 disrupted the association between CHIP and Hsp70 (Figure 3.11A) in a 
concentration dependent manor that was analogous to its effect on CHIP ubiquitin ligase 
activity (Figure 3.7). In contrast, and in spite of the fact that it has equivalent effects on 
Hsp70 nucleotide exchange (Takayama and Reed, 2001), BAG1 had little effect on CHIP-
Hsp70 interactions, even at relatively high molar ratios (Figure 3.11B), which is consistent 
with its inability to suppress CHIP E3 ligase activity toward NBD1 domain of CFTR 
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Figure 3.12 BAG2 induced dissociation of CHIP-Hsc/Hsp70 
complexes in HeLa cells. Coimmunoprecipitation of Myc-tagged 
CHIP and endogenous Hsc/Hsp70 was performed in HeLa cells 
transfected with or without HA-tagged BAG2. CHIP 
immunoprecipitates were blotted for the presence of BAG2 and 
Hsc/Hsp70 with specific antibodies. 
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Figure 3.13 ATP binding of Hsp70, CHIP and BAG2. ATP binding was 
assayed by 8-azido-32P-ATP photolabeling of the indicated proteins. Only 
Hsp70, but not CHIP or BAG2 was able to bind to ATP.  
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(Figure 3.8). We also found that BAG2 disrupted the association of CHIP and endogenous 
Hsc/Hsp70 in vivo (Figure 3.12). Therefore, this ATP dependent remodeling of the CHIP-
Hsp70 ubiquitin ligase complex into CHIP-BAG2 complex prevented Hsp70 to present 
substrates to CHIP, which results in the observed inhibition of the E3 ubiquitin ligase activity 
of CHIP (Figure 3.7).  
The nucleotide dependence of this protein complex remodeling raised the question of 
which of these proteins bound to, and had their functions affected by, ATP. We tested this by 
8-azido-ATP photolabeling, a sensitive index of ATP binding (Figure 3.13). As expected, 8-
Azido-ATP photoreacted with Hsp70, but not with CHIP or BAG2. Similar results were 
observed with 32P-ATP affinity chromatography (not shown). Taken together, these results 
suggests that remodeling of the Hsp70-BAG2-CHIP heterocomplex requires nucleotide 
binding to dissociate BAG2 from Hsp70 and (based on the effects of AMP-PNP) Hsp70-
dependent nucleotide hydrolysis to facilitate the BAG2-CHIP interaction. 
We have previously observed that stable interactions between CHIP and the ubiquitin 
conjugating enzyme UbcH5a are necessary for ubiquitin ligase activity (Jiang et al., 2001), 
we then examined whether direct interaction between CHIP and BAG2 had any effects on 
CHIP-UbcH5 interaction. In support of this hypothesis, we noted that incorporation of BAG2 
into CHIP complexes in the presence of ATP destabilized this interaction (Figure 3.14), 
preventing E2–E3 coupling that is required for ubiquitin chain assembly. Given the 
proximity of BAG2 and CHIP within the chaperone/ubiquitin ligase holocomplex, this 
activity provides an additional mechanism for inhibition of chaperone substrate 
ubiquitylation. Taken together, our observations suggest that BAG2 regulates multiple 
aspects of the activity of CHIP-Hsp70 ubiquitin ligase complex, and thus exerts a checkpoint 
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Figure 3.14 Disruption of CHIP E2-E3 coupling by CHIP. Interactions 
between UbcH5a (expressed as a His-tagged protein) with GST-CHIP were 
tested in the absence or presence of equimolar concentrations of BAG2. These 
binding reactions were performed in the presence of ATP (5 mM). 
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Figure 3.15 A model of the mechanism underlying the inhibitory effects of BAG2 
on CHIP ubiquitin ligase activity. In the absence of BAG2, a holocomplex containing 
CHIP, Hsp70, an E2, and chaperone substrate assembles to facilitate substrate 
ubiquitylation. Through its BAG domain, BAG2 makes contact with the ATPase 
domain of Hsp70 and additional remodeling of the complex occurs in an ATP-
dependent fashion that has 2 consequences. CHIP and BAG2 are dissociated from 
Hsp70, and binding of E2 to CHIP is uncoupled. 
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mechanism that may prevent dysregulated ubiquitylation of chaperone substrates. 
3.5 Discussion 
Protein quality control is essential for living cells to maintain their normal function and 
to cope with stress challenges. Molecular chaperones participate in both protein folding and 
degradation pathways of the cytoplasmic protein quality control system and their functions 
are regulated by a group of co-chaperones. One such co-chaperone, CHIP, inhibits the 
ATPase activity of Hsp70 in vitro, and activates HSF1 and increases the folding function of 
Hsp70 in vivo (Ballinger et al., 1999; Dai et al., 2003; Kampinga et al., 2003). Functioning in 
association with molecular chaperones Hsp70 and Hsp90, CHIP has also recently been 
shown to contains E3 ubiquitin ligase activity in facilitating chaperone substrate degradation 
(Connell et al., 2001; Meacham et al., 2001; Xu et al., 2002). Therefore, decision of whether 
to refold or to degrade chaperone substrates, termed as “protein triage”, may be made by 
modulating functions of chaperone complexes. In order to understand regulation of Hsp70-
CHIP complex, we immunopurified CHIP containing complexes in HeLa cell lines. We have 
found that BAG2 is a prominent component of CHIP-containing complexes, and it inhibits 
E3 ligase activity of the CHIP-Hsp70 complexes. 
BAG2 is one of six proteins that contain carboxyl-terminal BAG domains in 
mammalian cells. BAG domains of BAG family proteins all interact with ATPase domain of 
Hsp70 (Takayama and Reed, 2001); they induce conformational change of this domain, 
which results in nucleotide exchange (Sondermann et al., 2001). Many of the BAG-domain 
proteins possess anti-apoptotic activities through different mechanisms. However, we did not 
detect any effects of BAG2 on apoptosis by using a variety of techniques (data not shown). 
What we do find is that BAG2, but not BAG1, induces dissociation of CHIP from Hsp70 and 
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release of E2 from CHIP, thus inhibits E3 ligase activity of CHIP-Hsp70 complex in the 
presence of ATP. This unique function of BAG2 may rely on the amino terminus of this 
protein, since the amino terminus of the BAG family proteins have diverse structure and 
function (Takayama et al., 1999). The amino-terminus of BAG2 is required to stabilize the 
ternary BAG2-Hsp70-CHIP complex, suggesting that these sequences may form protein-
protein interactions within this complex—in addition to the BAG-ATPase domain 
interaction—to tune the molecular functions of this complex. Consistent with this model, 
ATP-dependent interaction of BAG2 with CHIP remodels the trimeric complexes so that 
Hsp70 is excluded (Figure 3.11). It is also plausible that the amino terminus of BAG2 
sterically hinders interaction between UbcH5 and CHIP, although we can not exclude the 
possibility that BAG2 also has conformational effects on the complex that determine the 
rules of E2-E3 association (Figure 3.15). 
Our work here provided a mechanism for the protein triage decision making by the 
inhibition of CHIP E3 ubiquitin ligase activity by BAG2. Our results indicate that BAG2 is 
likely to play a constitutive regulatory role in this decision, leaving regulation of this CHIP-
BAG2 interaction an open question. CHIP-BAG2 interaction is dependent on nucleotide, so 
manipulation of nucleotide availability to the CHIP-Hsp70-BAG2 complexes might play an 
important regulatory role. Recently, BAG2 was identified as a phosphorylation target for p38 
MAP kinase in a proteomic screen (Ueda et al., 2004); therefore, it is possible that functional 
regulation of BAG2 by phosphorylation might affect its association with CHIP-Hsp70 
complexes. However, we did not find the effects of BAG2 on CHIP were altered by 
pharmacologic inhibitors or activators of p38 (data not shown). How the interaction of BAG2 
with CHIP-Hsp70 is regulated remains to be elucidated. 
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Previous, the Hohfeld group reported that HspBP1 and BAG1 are able to affect the 
ubiquitin-proteasome degradation pathway mediated by CHIP. HspBP1 inhibited E3 ligase 
activity of CHIP, but with a mechanism different from disrupting E2-CHIP association 
(Alberti et al., 2004). BAG1 does not affect E3 ligase activity of CHIP, but stimulates CHIP-
mediated degradation by the ability of BAG1 to associate with the proteasome using a 
ubiquitin-like domain at its amino terminus that is not present in BAG2 (Demand et al., 
2001). We did not detect HspBP1 or BAG1 in our mass spectrometry experiment nor did the 
Hohfeld group that used a similar proteomic approach and identified BAG2, but not HspBP1 
nor BAG1 in CHIP-containing protein complex (Arndt et al., 2005), suggesting that 
interaction between HspBP1 with CHIP-Hsp70 complex is highly regulated or is not a 
dominant interaction in the experimental system that we were using. Nevertheless, we 
propose two hypotheses about the antagonistic effects of BAG1 and BAG2 toward CHIP-
dependent degradation. First, these two proteins may target different substrates of CHIP-
Hsp70 complex, since BAG2 modulate the degradation of CFTR while BAG1 does not. 
Second, they may participate in serial interactions with CHIP-Hsp70 complex to regulate its 
function. Interaction of BAG2 with Hsp70 induces ATP binding, substrate loading, and 
inhibition of ubiquitin ligase activity. BAG1 binding would in turn relieve BAG2-dependent 
inhibition of ubiquitylation, and would concomitantly facilitate transfer of chaperone 
substrates ubiquitylated by CHIP to the proteasome for ATP dependent degradation; 
although the lower affinity of BAG1 compared with BAG2 would argue that this might occur 
only under specific circumstances. Further experiments are required to support these 
hypotheses. Taken together, our data suggest that BAG2 regulates the ubiquitin ligase 
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activity of Hsp70-CHIP complexes and therefore governs the balance between folding and 
degradation of chaperone substrates. 
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Discussion and future directions 
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Molecular chaperones play a central role during stress response. They are induced upon 
stress challenges and bind to denatured proteins, helping them refolding and preventing them 
aggregating. Recently, it was suggested that they also assist the delivery of irreversibly 
damaged proteins for proteasomal degradation (Ellgaard and Helenius, 2001; Trombetta and 
Parodi, 2003). A protein triage model has been suggested for protein quality control. In that 
model, damaged proteins are recognized by molecular chaperones of the quality control 
system, and the competition between some E3 and E2 proteins of the ubiquitin-proteasome 
system and chaperones for binding to nonnative proteins determines the fate of refolding or 
degradation of those proteins (Wickner et al., 1999). However, recent work by the Patterson 
lab and other labs suggests that CHIP, a cochaperone that interacts with molecular 
chaperones Hsp70 and Hsp90 and increases the expression and refolding activity of 
chaperones in vivo (chapter two and (Kampinga et al., 2003)), also act as a chaperone-
dependent ubiquitin E3 ligase that polyubiquitylates chaperone substrates for proteasomal 
degradation (Connell et al., 2001; Jiang et al., 2001; Meacham et al., 2001), and thus is a well 
suited candidate that helps to determine the fate of chaperone substrates. We propose that 
CHIP increases the overall folding capacity of the cells during stress response, but if a 
protein is severely damaged and is beyond repair, CHIP then remodels the chaperone system 
into part of the degradation machinery by polyubiquitylating the chaperone substrate and 
sending it to the proteasome. Therefore, CHIP plays a pivotal role in decision making of 
protein quality control. 
4.1 Role of CHIP in the regulation of stress response 
Induction of heat shock proteins is essential in stress response. Heat shock proteins 
buffer the deleterious effects of stress by binding to unfolded proteins and preventing them 
 104
accumulating. Functions of heat shock proteins are tightly controlled by a group of 
cochaperones. CHIP was identified as one such cochaperone that inhibits the ATPase activity 
of Hsp70 and induces the release of chaperone substrates. The consequence is inhibited 
Hsp70 refolding activity by CHIP in vitro (Ballinger et al., 1999). However, overexpression 
of CHIP enhances Hsp70-dependent folding activity in mammalian cells (Kampinga et al., 
2003). Several explanations can reconcile the discrepancies between these two studies. In 
addition to the reasons presented in the introduction, in chapter II, we demonstrated that 
CHIP can induce the expression of Hsp70. Therefore, induction of Hsp70 by CHIP accounts 
for, at least partly, the increased overall folding activity of Hsp70 in vivo. 
Heat shock response is not only associated with induction of Hsp70 and the increased 
refolding capacity of the cell, but also with the inhibition of transcription and translation of 
proteins in general and cell cycle arrest (Lindquist, 1986; Rowley et al., 1993; Luft et al., 
2001). Although this may be beneficial for cells to cope with stress in the short term, 
unrestricted heat shock response is deleterious to the cells in the long run. The cells have 
evolved to use sophisticated mechanisms to keep the activity of HSF1 under tight control, 
including the regulation by Hsp70, Hsp90 and Hsp40, reversible phosphorylation and 
sumoylation, and sense heat and oxidative stress by HSF1 itself (see chapter one). In chapter 
II, we presented that CHIP interacts with Hsp70-HSF1 complex and remodels it to become a 
transcriptionally active complex that resists attenuation. In cells lacking endogenous CHIP, 
maximal induction of Hsp70 after heat shock is abolished. This work establishes an essential 
role of CHIP in the regulation of HSF1. 
Several other proteins have been implicated in affecting the activity of HSF1. Daxx, a 
modulator of apoptosis and a repressor of basal transcription, is capable of interacting with 
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the trimeric form of human HSF1. This interaction leads to the activation of HSF 1 
transcriptional activity and is required for maximal induction of Hsp70 after heat shock 
(Boellmann et al., 2004). Two lines of differences reside between the activation of HSF1 by 
CHIP and Daxx. First, CHIP interacts with Hsp70-HSF1 complexes before, during and after 
heat shock, although more CHIP protein is present in the Hsp70-HSF1 complexes during 
heat shock, while the nuclear protein Daxx only interacts with the trimeric form of HSF1 that 
has already bound to HSF. Second, overexpression of CHIP alone is sufficient to activate 
HSF1 and induce the expression of Hsp70, while overexpression of Daxx only minimally 
increases the transcription of Hsp70, but it induces transcriptional competence for pre-
trimerization HSF1. Therefore, CHIP and Daxx represent two independent mechanisms that 
activate HSF1. 
Two other proteins, Ral-binding protein 1 (RalBP1) and protein phosphatase 5 (PP5), 
have been reported as negative regulators of HSF1 activity. RalBP1 and HSF1 interact in 
vivo in a complex containing HSP90, α-tubulin and RalBP1·HSF1. Upon heat shock, the Ral 
signaling pathway is activated, resulting in the binding of RalBP1 by RalGTP. This is 
concurrent with the release of HSF1 from the RalBP1·HSF1·HSP90α-tubulin 
heterocomplexes, and translocation of HSF1 into the nucleus, where it then activates 
transcription (Hu and Mivechi, 2003). PP5, a TPR domain-containing component of Hsp90-
steroid receptor complexes also interacts with HSF1-Hsp90 complexes. Overexpression of 
PP5 or activation of endogenous phosphatase activity results in diminished HSF1 DNA 
binding and transcriptional activities, and accelerated recovery. Depletion of PP5 by antibody 
or inhibition of its phosphatase activity in vivo significantly delays trimer disassembly after 
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heat shock (Conde et al., 2005). Inhibition of HSF1 by these two proteins represents the 
regulation of HSF1 by intracellular signaling pathways. 
Regulation of HSF1 by proteins other than molecular chaperones represents a new 
mechanism for the regulation of HSF1 that is incorporated into the already complicated 
regulatory system. Although in each individual study, the factors reported (chaperones, 
phosphorylation sites, cysteine residues, CHIP, Daxx, etc) seem to be required for maximal 
induction or inhibition of HSF1 activity in their particular experimental system, the relative 
abundance of each regulator and activity of signaling pathways may determine the relative 
importance of each regulatory mechanism in different organs, tissues and cell types. The 
detailed mechanism for the regulation of HSF1 still needs to be elucidated.  
We observed an antiapoptotic effect of CHIP. CHIP protects cultured fibroblasts from 
heat-induced apoptosis (Chapter II), and also protects cells of the gastrointestinal tract and 
spleen from apoptosis induced by thermal challenge of mice (Dai et al., 2003). Although the 
fact that CHIP coordinates folding, degradation and the global stress response, each of which 
probably contributes to its antiapoptotic effects, we were still interested in investigating if 
CHIP directly interferes with the apoptotic pathways.  
ASK1 (Apoptosis signal-regulating kinase 1) is a MAPKKK (mitogen-activated 
protein kinase kinase kinase) that is regulated under conditions of cellular stress. ASK1 
phosphorylates c-Jun N-terminal kinase (JNK) and elicits an apoptotic response. Because 
ASK1 is known to contain a TPR-acceptor site, our lab examined the role of CHIP in 
regulating ASK1 function. CHIP interacts with ASK1 in a TPR-dependent fashion and 
induces ubiquitylation and proteasome-dependent degradation of ASK1. Targeting of ASK1 
by CHIP inhibits JNK activation in response to oxidative challenge and reduces ASK1-
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dependent apoptosis. CHIP also triggers the translocation of ASK1 partner protein Daxx into 
the nucleus, where it is known to activate an antiapoptotic response. This work elucidated a 
mechanism for CHIP to interfere directly with and regulate the apoptotic pathway in the face 
of cellular and physiologic stress (Hwang et al., 2005). 
CHIP is highly expressed in striated muscles (skeletal muscle and heart), making them 
the most appropriate targets to examine the endogenous function of CHIP in the setting of 
stress challenge. Our lab tested the response of CHIP(−/−) mice to in vivo ischemia and 
reperfusion injury induced by left anterior descending coronary artery ligation. We found that 
compared with their littermates, CHIP(−/−) mice have decreased survival and increased 
incidence of arrhythmias during reperfusion, which is accompanied by increased infarct size, 
impaired upregulation of Hsp70 and increased numbers of apoptotic cells in the myocardium 
and intramural vascular endothelium(Zhang et al., 2005). This work demonstrates that the 
chaperone system, including CHIP, plays a necessary role in protection against stress induced 
damages under pathophysiologically relevant conditions. 
4.2 Role of CHIP as a chaperone dependent ubiquitin E3 ligase 
Ever since the discovery that the U-box of CHIP has E3 ubiquitin ligase activity (Jiang 
et al., 2001; Murata et al., 2001), dozens of substrates have been assigned to CHIP, which 
can be broadly categorized into two groups: (1) signaling molecules, such as GR (Connell et 
al., 2001; Xin et al., 2005), unliganded ER (estrogen receptor) (Tateishi et al., 2004), Smad 
family proteins (Li et al., 2004), ErbB2 (Xu et al., 2002; Zhou et al., 2003), nucleophosmin-
anaplastic lymphoma kinase (NPM-ALK) (Bonvini et al., 2004), nNOS (Peng et al., 2004), 
and (2) mutant or aggregation-prone proteins such as mutant CFTR (Meacham et al., 2001; 
Younger et al., 2004), menin missense mutants (Yaguchi et al., 2004), wild type and mutant 
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p53 (Esser et al., 2005), and phosphorylated tau (Hatakeyama et al., 2004; Petrucelli et al., 
2004; Shimura et al., 2004). The common feature of these proteins is that they are 
structurally labile and that they need to associate with molecular chaperones Hsp70 or Hsp90 
to maintain their activation-competent state or to prevent them from aggregation. By 
polyubiquitylating and degrading these proteins, CHIP helps to modulate intracellular 
signaling and to regulate chaperone-dependent protein quality control.   
As mentioned before, degradation of the first signaling molecule identified by CHIP is 
GR (Connell et al., 2001). Recently, estrogen-unbound (unliganded), especially misfolded 
ERα is found to be another CHIP substrate (Tateishi et al., 2004). These two proteins belong 
to the nuclear receptor superfamily. Upon binding to their ligands, they undergo a 
characteristic conformational change to gain DNA binding activity and activate transcription. 
Unliganded receptors are not stable and they need to associate with chaperones Hsp90 (GR) 
or Hsp90, Hsp70, and Hsp40 (ERα) to maintain their activation-competent state. 
Overexpression of CHIP induces degradation of GR and unliganded, especially misfolded 
ERα, while in cells lacking endogenous CHIP, degradation of unliganded ERα is blocked 
(Connell et al., 2001; Tateishi et al., 2004). These two studies suggest that CHIP regulates 
protein quality control of nuclear receptor family proteins, and at least for ERα, this 
regulation is relevant under physiological conditions with endogenous CHIP. CHIP has also 
been shown to decrease the steady-state protein levels of androgen receptor (He et al., 2004). 
It is therefore interesting to explore if CHIP has E3 ubiquitin ligase activity toward other 
nuclear receptor proteins. 
Recently molecular chaperones have been implicated in facilitating malignant 
transformation by binding to overexpressed or structurally labile oncoproteins, thus buffering 
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genetic instability that is characteristic of many human cancers. Chaperone inhibitors, 
especially Hsp90 inhibitors geldanamycin and 17-AAG, are becoming a promising new 
family of anti-cancer drugs. By inhibiting Hsp90 function, Hsp90 inhibitors promote the 
destabilization and down-regulation of these oncoproteins that results in anti-cancer effect 
(Bagatell and Whitesell, 2004). Degradation of several Hsp90 bound oncoproteins, such as 
overexpressed ErbB2 (Xu et al., 2002; Zhou et al., 2003; Bagatell and Whitesell, 2004) and 
mutant p53 (Esser et al., 2005), is mediated by the E3 ligase activity of CHIP. In the presence 
of GA or 17-AAG, degradation of these oncoproteins is more prominent. Since Hsp90 has an 
essential role in signal transduction and protein folding, general inhibition of Hsp90 function 
leads to a profound adverse effect. Conjugation of Hsp90 inhibitor and CHIP might be a 
selective therapeutic approach for certain cancers. Also the expression level of CHIP might 
be an important determinant of the therapeutic success of such pharmacological 
interventions. Down-regulation of p53 by CHIP also provides a mechanism for CHIP-
dependent anti-apoptotic effect during heat shock stress.  
 CFTR is a cytoplasmic membrane chloride channel, the mutation of which leads to 
cystic fibrosis. The biogenesis of CFTR is inefficient since 60-75% of the wild type and 99% 
of the mutant CFTR is degraded during their synthesis in the ER (Ward and Kopito, 1994). 
CHIP, Hsp70 and Hdj2 forms a ubiquitin ligase complex that polyubiquitylates and degrades 
immature CFTR during its synthesis in the ER. Inactivation of this E3 ligase complex leads 
to accumulation of the major mutant CFTR∆F508 in a nonaggregated state, which upon 
lowering of temperature, can fold and reach the cell surface. Therefore, although ER 
associated degradation of the biogenesis intermediate of the CFTR mutant prevents it from 
forming aggregates, it also prevents the folding-competent intermediate to mature to the cell 
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membrane that leads to the manifestation of the disease (Younger et al., 2004). Quality 
control of immature CFTR mediated by this CHIP-dependent E3 ligase complex results in a 
deleterious effect, and inhibition of this ubiquitin ligase provides a new therapeutic approach 
to treat CF.  
The canonical ubiquitin-proteasome degradation system is characterized by 
polyubiquitin chain formation via lysine 48 linkage onto substrates that leads to their 
proteasomal degradation. Exceptions occur in this system, including for CHIP substrates. 
Linkages of polyubiquitin chain other than lysine 48 occur on CHIP substrates. Hsc70, the 
original CHIP substrate identified, is polyubiquitylated via either lysine 29 or lysine 63 
linkages, and polyubiquitylation of Hsc70 does not result in degradation, but is of an 
unknown function (Jiang et al., 2001). The cochaperone BAG1, which enhances CHIP 
substrate degradation by presenting CHIP substrates to the proteasome via its ubiquitin-like 
domain (Demand et al., 2001), is ubiquitylated by CHIP through lysine 11 (Alberti et al., 
2002). This ubiquitylation does not induce degradation of BAG1, but stimulates the 
association of BAG1 with the proteasome (Alberti et al., 2002). Thus, BAG1 ubiquitylation, 
in conjugation with Hsc70 ubiquitylation, may act as a sorting signal for delivering 
polyubiquitylated CHIP substrates to the proteasome.  
Polyubiquitylation of substrates by CHIP does not always results in degradation. Epsin, 
an endocytic adaptor protein that is involved in the regulation of clathrin-dependent 
endocytosis, is polyubiquitylated by CHIP. However, polyubiquitylation of Epsin by CHIP 
does not require molecular chaperones Hsp70 nor Hsp40, and polyubiquitylated Epsin does 
not lead to proteasomal degradation (Timsit et al., 2005). Like Hsp70 ubiquitylation, the 
function of Epsin ubiquitylation by CHIP is unknown.  
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The expression of CHIP is not ubiquitous, but restricted to a few organs. In addition to 
striated muscles, the brain is the second organ that CHIP is highly expressed (Ballinger et al., 
1999).  Given the role that CHIP plays in protein quality control, it is not surprising that 
CHIP is implicated in a variety of neurodegenerative diseases, such as Alzheimer’ disease 
(AD) (Petrucelli et al., 2004; Shimura et al., 2004; Sahara et al., 2005), amyotrophic lateral 
sclerosis (ALS) (Urushitani et al., 2004), and familial Parkinson’s disease (PD) (Imai et al., 
2002). 
There is no consensus of the role CHIP plays in tau-associated neurodegeneration 
diseases. Aggregation of hyperphosphorylated, microtubule-associated protein tau is 
characteristic of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s 
disease. However, it is not clear whether hyperphosphrylated soluble tau, or the 
polyubiquitylated tau aggregates, is toxic to neurons. Overexpression of CHIP leads to 
polyubiquitylation of hyperphosporylated tau, which results in increased degradation 
(Shimura et al., 2004) or aggregation (Petrucelli et al., 2004) of tau proteins, and increased 
cell survival (Shimura et al., 2004). An in vivo study shows that CHIP proteins levels are 
inversely proportional to tau accumulates in AD brain samples. In aged mice lacking CHIP, 
there is an increased level of insoluble tau (Sahara et al., 2005). Taken together, these studies 
suggest that by polyubiquitylating hyperphosphorylated tau proteins, CHIP exerts a neuronal 
protective role in taupathies. Examination of CHIP knock out mice may lead to the 
understanding of the pathogenesis of taupathies.  
CHIP plays an additional role in the ubiquitin-proteasome pathway. UFD2 is the yeast 
U-box protein classified as an E4 ubiquitin chain elongation factor. UFD2 cannot cooperate 
directly with E2 enzymes to ubiquitylate substrates, but functions in conjunction with an E3 
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ligase to elongate the polyubiquitin chain on substrates (Koegl et al., 1999). The U-box of 
CHIP contains such E4 activity during the degradation of Pael receptor (Pael-R) by the 
RING-finger containing E3 ligase Parkin, whose mutation is responsible for familial 
Parkinson’s disease. CHIP forms a complex with Hsp70, Parkin and Pael-R and promotes the 
dissociation of Hsp70 from Parkin and Pael-R, thus facilitating and enhancing Parkin-
mediated Pael-R ubiquitylation (Imai et al., 2002). CHIP and Hsc70 also forms a 
preubiquitylation complex (PUC) with E47 and Skp2 and facilitates the ubiquitylation and 
degradation of E47 by Skp2 during lymphocyte development (Huang et al., 2004). Both the 
E4 activity and the formation of PUC facilitate substrate ubiquitylation, thus CHIP can act as 
a cofactor for the ubiquitin-proteasome pathway to facilitate protein quality control in 
addition to being an E3 ligase. 
4.3 Other functions of CHIP in protein quality control 
Functions of CHIP other than the regulation of stress response and substrate 
ubiquitylation have emerged. CHIP can interfere with intracellular trafficking. CHIP interacts 
with Hsp90/eNOS complex and decreases the soluble eNOS levels. However, CHIP does not 
ubiquitylate eNOS and induce its degradation, but interferes with the trafficking of eNOS 
from the Golgi apparatus to the plasma membrane. Therefore eNOS is partitioned into an 
inactive intracellular compartment rather than mature through the Golgi apparatus and arrive 
onto the plasma membrane (Jiang et al., 2003). This represents a novel mechanism for CHIP 
to down-regulate chaperone substrates, which is distinct from the utilization of the ubiquitin-
proteasome system. What the physiological significance of this regulation is and whether 
other chaperone substrates are regulated by a similar mechanism remain to be elucidated.  
4.4 Regulation of CHIP function 
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Given the importance of CHIP in protein quality control, it is necessary to tightly 
control the activity of CHIP to prevent unnecessary activation of the stress response or global 
diversion of chaperone substrates to the proteasomal degradation pathway. The regulation of 
CHIP activity is not completely understood. The steady-state protein levels of CHIP are 
largely unchanged during stress challenges in cultured cells and in mouse tissue ((Tateishi et 
al., 2004) and chapter two), except the observation that CHIP protein levels are upregulated 
during ER stress induced by tunicamycin in a neuroblastoma cell line (Imai et al., 2002). 
Therefore several labs set out to examine the functional regulation of CHIP. 
CHIP is posttranslationally phosphorylated on serine and threonine residues (Hwang 
and Patterson, unpublished observation). However, how these phosphorylations affect CHIP 
function and the kinases that responsible for these phosphorylations are unclear. 
CHIP forms homodimers at physiological concentrations. The central charged region 
that is predicted to form coiled-coil domain is necessary and sufficient for dimer formation. 
A CHIP mutant that lacks this segment also loses its E3 ubiquitin ligase activity. This is the 
first evidence that the function of CHIP can be regulated by manipulation of its dimerization 
states (Nikolay et al., 2004). However, although the authors claim that the large deletion 
mutation of hCHIPdelta-(128-229) does not affect the structure of the remaining TPR or U-
box domain, and thus the loss of E3 ligase activity is due to the inability to dimerize, it is 
plausible that such a large deletion to a relatively small protein (about one third of the full-
length protein) might have a profound effect on the functional integrity of this protein. One 
possible effect might be the bringing of the TPR domain and the U-box close together, 
therefore generating steric hindrance that prevents the interaction of the U-box with E2 
enzyme. Point mutations in the proposed dimerization domain need to be examined to 
 114
understand the residues that are important for dimerization and its effects on CHIP E3 ligase 
activity. 
During my study of CHIP function, I set out to detect protein factors that associate with 
CHIP and the functional consequences of this interaction. I found that BAG2 is a major 
component of CHIP containing complex. Hsp70 serves as a bridge that forms a BAG2-
Hsp70-CHIP complex. In the presence of ATP, BAG2 associates directly with CHIP, which 
disrupts CHIP-Hsp70 and CHIP-E2 interaction and leads to inhibition of CHIP E3 ligase 
activity. Thus BAG2 acts an inhibitor of CHIP E3 ligase activity (chapter 3). It has been 
previously reported that HspBP1 inhibits E3 activity of CHIP toward the Hsc/Hsp70 bound 
substrates of Raf1, denatured luciferase, and CFTR, and promotes CFTR maturation (Alberti 
et al., 2004). Two lines of differences exist between BAG2 and HspBP1 in their regulation of 
CHIP. BAG2 is much more abundant in the CHIP containing complex than HspBP1. BAG2 
is a major band that is readily detectable from the CHIP IP complexes resolved by SDS-
PAGE and silver staining, while HspBP1 can only be detected by Western blotting of the 
CHIP containing complexes (chapter 3 and (Alberti et al., 2004)). This suggests that BAG2 is 
a major regulator of CHIP function at physiological conditions, while HspBP1 might become 
a major regulator under certain circumstances that its interaction with CHIP is upregulated, 
or in certain tissues that CHIP-HspBP1 complexes are abundant. Second, they have different 
mechanism of inhibition. BAG2 disrupts the CHIP-Hsp70-E2 ubiquitylation machinery 
(chapter 3 and (Alberti et al., 2004)), while HspBP1 does not, but may induce conformational 
change of the E3 complex (Alberti et al., 2004). It is interesting to note that when we 
submitted our manuscript of the CHIP-BAG2 interaction story for review, we were informed 
that the Hehfeld group submitted a similar manuscript to the same journal. Fortunately, our 
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paper was published before theirs. I was surprised to find the strikingly similarity between 
the two papers when their paper was published (Arndt et al., 2005), which indicates the 
reproducibility of our data. Degradation of chaperone substrates by CHIP constitutively is a 
heavy burden for the cells because vast amount of energy is wasted when used for synthesis 
of these proteins. Here the work of the Hehfeld group and ours suggests that additional 
protein co-factors help to regulate E3 ligase activity of CHIP and determine the fate of its 
substrates. 
 Previously the Hehfeld group reported that BAG1 promotes CHIP substrate 
degradation. BAG1 does not affect E3 ligase activity of CHIP, but facilitates 
polyubiquitylated CHIP substrates to the proteasome, which is mediated by the association of 
the ubiquitin-like domain of BAG1 to the proteasome (Demand et al., 2001). 
To date, BAG2, HspBP1 and BAG1 are the only proteins that have been identified to 
modulate the function of CHIP in the ubiquitin-proteasome degradation pathway. The 
common feature of these proteins is that they are all Hsp70 cochaperones that regulate Hsp70 
nucleotide states. It is conceivable that since they have affinity for Hsp70, they gain access to 
the CHIP-Hsp70 ubiquitin ligase complex and modulate its activity. It is interesting to 
explore if other Hsp70 cochaperones have similar activity toward the CHIP-Hsp70 ubiquitin 
ligase dependent protein degradation pathway. 
4.5 Future directions 
We now know that CHIP is a link between the chaperone and the proteasome system, 
and thus plays an important role in protein quality control. As our knowledge about the 
function of CHIP increases exponentially, more questions are generated during the course of 
investigation: 
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1. Regulation of stress response. We have shown that CHIP forms a complex with 
Hsp70-HSF1 that is transcriptionally competent. Since protein levels of CHIP are largely 
unchanged during stress, what signals CHIP to associate with Hsp70-HSF1 and activate 
transcription? Does CHIP sense heat stress itself or other signals such as dimerization or 
phosphorylation of CHIP serve as a signal? What suppresses the activity of this complex 
when stress signals subside?  
2. CHIP acts as a chaperone-dependent E3 ligase. CHIP polyubiquitylates dozens of, 
but not all chaperone substrate. What determines the substrate specificity of CHIP? What 
determines the lysine residues of ubiquitin that are used to form polyubiquitin chain on 
substrates by CHIP? What determines the fates of polyubiquitylated CHIP substrates, to the 
degradation or degradation-independent pathway? What is the function of CHIP in the 
pathogenesis of polyQ diseases and taupathies? 
3. Regulation of CHIP. CHIP regulates both arms of protein triage by enhancing the 
refolding capacity of the cell and by diverting chaperone substrates to the degradation 
machinery. The central question to this system is how CHIP determines to refold some 
chaperone substrates while degrading others. Is it affected by nucleotide binding states of 
chaperones, association with other cochaperones, or regulation of CHIP function? How does 
phosphorylation or other posttranslational modifications regulate CHIP function? What are 
the enzymes responsible for and what regulates these modifications? Is dimerization of CHIP 
important for its function? What functions of CHIP are affected by modulating its 
dimerization states? What determines the dimerization states of CHIP? Since CHIP-Hsp70-
BAG2 form a stable complex that is not affected by stresses such as heat shock, what is the 
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physiological importance of this regulation? How is inhibitory activity of BAG2 on CHIP 
regulated during normal and stress conditions? Are there other regulators of CHIP? 
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